Optical spectroscopy and imaging systems for gynecological cancers:
from Ultraviolet-C (UVC) to the Mid-infrared by Appiah, Benjamin
Rice University 
Optical spectroscopy and imaging systems for gynecological cancers: 
from Ultraviolet-C (UVC) to the Mid-infrared 
by 
Benjamin Appiah 
A THESIS SUBMITTED 
IN PARTIAL FULFILLMENT OF THE 
REQUIREMENTS FOR THE DEGREE 
Doctor of Philosophy 
APPROVED, THESIS COMMITTEE: 
R~k, ~ioengineering, 
Electrical & Computer Engineering 
Thesis Committee C 
~f~ 
Kevin Kelly, Asso ia Professor 
Electrical and Computer Engineerin 
obert M. Raphael, Associate Professor 
Bioengineering 
~Z~ 
Genevera Allen, Assistant;Professor 
Statistics 
Houston, Texas 
January 2011 
Abstract 
Optical spectroscopy and imaging systems for gynecological 
cancers: from Ultraviolet-C (UVC) to the Mid-infrared 
by 
Benjamin Appiah 
Optical spectroscopy and imaging has proving to be of diagnostic relevance in many 
organ sites. We use fluorescence and FTIR spectroscopy to study gynecological organ 
sites and develop classification algorithms for cancer diagnosis. Ovarian cancer is the 
deadliest gynecological cancer. The American Cancer Society reports that for the year 
20 I 0, there would be 21,880 new cases of ovarian cancer and 13,850 fatalities. This is 
partly due to the fact that current diagnostic and screening methods for the disease are not 
very accurate. In this study, we analyze the fluorescence spectra of excised normal and 
cancerous ovarian tissues at multiple excitation wavelengths. The data includes spectra 
obtained at the UVC wavelength 270nm and UVB wavelength 300nm. Excitation in the 
UVC has been especially understudied in spectroscopy for tissue diagnosis. We introduce 
the application of a novel SVM algorithm for the classification of fluorescence data. This 
SVM is trained subject to the Neyman Pearson (NP) criterion which allows for a decision 
rule that maximizes the detection specificity whilst constraining the sensitivity to a high 
value. This technique allows us to develop a binary classification algorithm that is not 
biased towards the larger group and this in tum leads to robust classifiers that are more 
suitable for clinical applications. We obtained sensitivities and specificities greater than 
90% for ovarian cancer diagnosis using this algorithm. Also, FTIR is used to analyze 
cervical tissues. Absorption of light in the mid-IR region by biomolecules show up as 
peaks in the FTIR spectra, and there is differential absorption in tissue depending on the 
histopathology. The spectroscopic analysis informed our choosing of a wavelength for 
the illumination source ofa mid-IR microscope. We then present the design of an 
imaging system that employs the use ofa mid-IR quantum cascade laser(QCL) which can 
potentially have clinical use in the future. Finally a reflectance based fiber endoscope 
imaging system is presented. Cellular imaging is demonstrated with this system that has 
the potential for use in optical biopsy. 
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Chapter 1: Introduction 
1.1 Motivation 
Gynecological cancers affect the organs and tissue ofthe female reproductive 
system. Among these, ovarian cancer is the most lethal having the highest mortality rate. 
Unlike other cancer types, very little is known about ovarian precancerous lesions and 
this contributes to the majority of ovarian cancer cases being diagnosed in the late stages. 
Cervical cancer on the other hand has well known precancerous lesions and the 
introduction of the Pap smear procedure has drastically decreased the mortality rate of the 
disease. It is nonetheless the second most common cancer affecting women. The 
definitive diagnosis for any gynecological cancer involves biopsy, a surgical procedure 
followed by microscopic examination. Fluorescence spectroscopy and imaging 
techniques have proven to be effective methods for tissue diagnosis and some 
spectroscopy systems have gained Food and Drug Agency (FDA) approval for use as 
adjunctive methods in the diagnosis of cancer. These systems use classification 
algorithms for automated diagnosis of the disease while biopsy and subsequent 
examination is a subjective process dependent on the skill ofthe examiner. A review of 
the literature indicates that in the training of classification algorithms, the size of the 
control group (normal) is usually larger, and in many cases much larger than the size of 
the malignant (cancer) group. Such algorithms may be prone to skewed classification 
results since they train for a decision rule that maximizes overall classification accuracy. 
Obviously well tailored algorithms that avoid this problem would no doubt make the 
systems already on the market or that are being evaluated function better. We present the 
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application of a classification algorithm that can help prevent the skewed classification 
problem. 
Moreover current fluorescent spectroscopic systems are in need of improvement 
in their diagnostic accuracy. We present the classification results of spectroscopic data 
excited at the UVC wavelength of270nm and show that it is a diagnostically significant 
wavelength in ovarian tissue diagnosis. The UVC wavelength region has been neglected 
due to concerns about tissue mutagenicity, but a number of studies support the fact that 
low power levels of excitation are safe. Incorporating UVC excitation wavelengths in 
current systems may lead to better classification results. 
The strong light absorption oftissues in the Mid-infrared (mid-IR) makes it 
challenging for optical systems operating in this wavelength region to be used for 
diagnosis. But many molecules have their vibrational modes excited in this wavelength 
region. Many of these molecules are tissue constituents and they exhibit distinct 
absorption peaks throughout the mid-IR region. We study the Fourier transform infrared 
(FTIR) absorption spectra of cervical tissue samples and after noting diagnostically 
significant wavelengths, we proceed to assemble a reflectance based mid-IR imaging 
system that use a high brightness quantum cascade laser (QCL) as an illumination source. 
Our hope is that in the future, optimized versions of such systems may help in the 
evaluation and diagnosis of tissues. 
Also the use of fiber probes for endoscopy holds promise for in vivo diagnosis in 
a lot of tissue sites that may be difficult to access non-invasively. We develop a 
reflectance-mode fiber microendoscope (RFM) system that is low cost and may have 
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potential for cancer diagnosis in the future. The algorithms, spectroscopy and imaging 
systems we have developed hold a lot of promise for aiding in the diagnosis of 
gynecological cancers. 
1.2 Specific Aims 
The goal is to develop algorithms and optical systems that would be useful as stand 
alone or adjunctive methods for the diagnosis of gynecological cancers and cancer in 
other organs as well. The specific aims for this thesis are: 
1. To demonstrate the application of a Neyman Pearson (NP) SVM algorithm that 
yields balanced classification results for discriminating ovarian cancer spectra 
from that of other tissue types regardless of the relative group size. 
2. To demonstrate the diagnostic potential ofUVC excitation fluorescence. 
3. To develop a reflectance-mode fiber microscope (RPM) for possible endoscopic 
or biopsy applications. 
4. To study FTIR mid-IR absorption spectra of formalin-fixed cervical tissues and to 
develop classification algorithms for discriminating between spectra of cervical 
cancerous and normal tissues. 
5. To present work on the development ofa reflectance mode QCL microscopy 
system. 
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1.3 Dissertation Overview 
Chapter 1 gives a short overview of optical spectroscopy, fiber probes for 
Ultraviolet-visible (UV-Vis) endoscopic imaging, ovarian and cervical cancer. Chapter 2 
presents measurement of the ovarian fluorescence spectra. Chapter 3 presents work on 
fluorescence spectroscopy and classification of ovarian tissues. The learning method of 
Support Vector Machines (SVM) is introduced and the Neyman Pearson(NP) training of 
ovarian fluorescence spectra for cancer diagnosis is presented. Chapter 4 presents the 
development and applications of the reflectance-mode fiber microscope. Chapter 5 
presents the classification algorithms for the diagnosis ofFTIR cervical spectra, 
discriminating between cancerous and normal tissues. Chapter 6 presents the 
development of the QCL based Mid-IR imaging system. Chapter 7 summarizes the thesis. 
1.4 Optical Spectroscopy 
Optical Spectroscopy deals with extracting information from the interaction 
between light and biological tissue. The information spectroscopy affords us include 
biochemical morphological properties of the tissue under interrogation. These properties 
change with the progression oftissues from normal to cancer, hence by using 
spectroscopy to access these properties we uncover information that can guide us in 
determining tissue histopathology. Some of the common spectroscopic modalities include 
fluorescence, diffuse reflectance, Fourier transform infrared spectroscopy (FTIR) and 
Raman spectroscopy. Each of the modalities provides some information about the tissue 
that may be exploited for differentiating between different tissues types or for diagnostic 
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purposes. For example diffuse reflectance provides information about absorption and 
scattering properties which have been observed to be different for diseased and normal 
tissues and light scattering spectroscopy gives us information about nuclear size 
distribution in the epithelial layer, a property which has been observed to be a feature of 
precancerous and cancerous changes. 
In this thesis, we used FTIR and fluorescence spectroscopy to develop 
classification algorithms for cervical and ovarian tissues respectively. The mechanism of 
fluorescence involves the excitation of a molecule (in the UV -Vis) into a higher energy 
level and its eventual relaxation to the ground state, accompanied by the emission of 
photons of a longer wavelength. The information accessed with fluorescence 
spectroscopy includes tissue biochemistry and the concentration of these biomolecules. 
FTIR involves the use of a broadband light source and a Michelson interferometer, to 
collect an interferogram of the tissue and then converts the interferogram to a spectrum 
by a Fourier transform algorithm. The information we can access in tissues is the distinct 
molecular vibrations which get excited at specific wavelengths in the mid-IR. Differences 
in the functional groups of molecules of cancerous and normal tissues can be utilized for 
classification purposes. 
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1.5 Survey of Fiber Optics Imaging and Endoscopy in the UV -Vis 
Typically, fiber-optic imaging or endoscopic systems operating in the Ultraviolet-
visible region (UV-Vis) use a fiber-optic cable for illumination and collection of light via 
a lens system. Conventional endoscopic applications often utilize a broadband light 
source for illumination ofthe sample. This has a limiting effect on the image contrast, as 
well as confines imaging to the surface of the sample eliminating the effective use in 
optical sectioning. The use of a filter to narrow the bandwidth of the source, usually 
selecting light in the blue region for illumination has been shown to improve image 
contrast. I-3 Also fiber-scanning confocal microscopy is a technique that has shown a lot 
of promise. Confocal microscopy itself allows for the selective imaging of different 
layers of tissue. It does this by the use of point illumination and a pinhole to eliminate 
out-of-focus light in tissue specimens thicker than the focal plane. This is a significant 
advantage over conventional wide-field microscopy and even allows for three-
dimensional imaging capability by scanning many thin sections. In the focal plane, all 
points from areas outside of the focal point are also blocked by the pinhole screen and 
this ensures enhanced lateral resolution. With the addition of a fiber probe and a simple 
lens system to a standard confocal microscope, a fiber-scanning confocal system can be 
realized. This system has great potential for in vivo imaging but requires a scanning 
system which sweeps through the fiber end, objective lens or specimen to record the 
images. Scanning mechanisms that have been used in fiber-optic imaging include 
piezoelectric driven tip tilt mirrors, piezoelectric actuators to facilitate compact scanning 
and miniaturized microelectromechanical systems (MEMS) scanning mirrors which can 
be as small as O.5mm.4-5 
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Fluorescence imaging with fiber probes have been reported in a number of 
studies.4,6 The fluorescence technique can increase contrast and enhance quality of 
images. Polglase et al. developed a confocal endomicroscope for the in vivo fluorescence 
imaging of the upper and lower GI tract. With the use of intravenously administered 
fluorescein and topically applied acriflavine, clear images including the nuclei of the GI 
tract were obtained.7 A notable study involving the use ofa fiber-optic confocal system 
for in vivo imaging of human skin has been reported by Swindle et al. 8 They reported the 
imaging of different layers of the skin and found detailed changes in skin morphology as 
deeper layers were imaged. For instance their findings included changes in keratinocyte 
size and shape with progressive imaging into deeper layers of the epidermis which 
suggest the ability of this technique to give valuable insight into depth-dependent tissue 
morphology. However, the use of exogenous fluorophores in the studies cited above pose 
the problem of possibly altering the tissue microenvironment which in tum makes it 
difficult to interpret the imaging results for disease detection.9 Relying only on 
endogenous tissue fluorescence signals can sidestep the issues with exogenous agents. 
However, autofluorescence compared to exogenous fluorescence applications generally 
suffer from low intensity and also suboptimal specificity. Nevertheless significant 
autofluorescence work has been reported. Mayinger et al: used the technique to 
discriminate between normal and cancerous tissues ofthe esophagus by noting the higher 
intensity signal of the normal tissues.! 0 A combination of fiber-optic autofluorescence 
and reflectance imaging was used to form composite images for the discrimination of 
early esophageal cancer tissues.!! 
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Advances particularly in photonic crystal fiber technology has encouraged the 
extension of fiber optic imaging into applications involving two-photon imaging.4,12-13 In 
this application, the use of photonic fibers ensure the delivery of femtosecond pulses with 
vastly reduced distortion, pulsed width broadening and modal interference. This has 
facilitated the design of a handheld miniaturized two-photon microscope which has been 
used for the imaging of diseased skin tissues. 13 An extremely compact fiber optic two-
photon system using a multimode fiber collector has also been used to acquire quality 
fluorescent images of animal tissues. 14 Two photon systems have the advantage that they 
can be used in imaging at different layers of a tissue just like the confocal systems and 
even enjoy deeper penetration into tissues, but the femtosecond pulse lasers used for 
excitation are very expensive. Fiber probes have also been used with other optical 
techniques such as optical coherence tomography(OCT)15, Ramanl6 and FTIR17, for 
studying biological tissues. Employing fiber-optic bundles for imaging instead of single 
fibers has also been considered. Fiber bundles are made of up to around 100,000 
individual fibers in a tightly packed arrangement which is consistent throughout its length. 
This allows for the transmission of the image of samples in a pixilated form. Muldoon et 
al. reported the development of a low cost fiber-bundle microscope for the fluorescence 
imaging of BarreU's esophagus.18 Their objective was to build a low cost system, and the 
components ofthe system added up to less than $2500. Subsequently a study involving 
ex vivo tissues was done and a quantitative image analysis algorithm using textural 
features was used to obtain a sensitivity of 87% and a specificity of 85% for identifying 
I . I' . h h 19 neop ashc eSlOns m t e esop agus. 
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In this thesis, the design and development of a high-resolution fiber bundle 
reflectance-mode (RPM) microendoscope is presented?O The endoscopic system has a 
resolution of around 3.5um and was designed for use in optical tissue biopsy. Also, it is 
low cost and can be easily converted for use in fluorescence imaging with minimal effort. 
Moreover the use of a fiber bundle eliminates the need for scanning as the light source 
was fully coupled into the bundle, cutting down on system complexity. 
1.6 Gynecological Cancer 
1.6.1 Ovarian Cancer 
Fallopian t:ubes 
Figure 1.1- Anatomical image of the female reproductive system showing organs that are 
affected by gynecological cancer. Courtesy of the Centers for Disease Control and 
Prevention and from Reference 21. 
Ovarian cancer has the highest mortality of all gynecological cancers. Overall, it 
is the fifth leading cause of all cancer deaths in women. The underlying biology of the 
disease is still being explored and currently not well understood. The most common type 
of the disease originates from the epithelium which accounts for about 85%-95% of the 
total. Rarer types can be found in the stroma of the ovary and the germ cell which is the 
egg producing cell of the organ. Other tissue abnormalities include benign tumors, which 
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is growth of abnormal cells that don't pose a risk of spreading to other sites, and cysts. It 
is estimated that only 20% ofthe disease is detected before tumor metastases. One of the 
main reasons is the lack of understanding of early symptoms of the disease. Figure 1.1 is 
an image of the female reproductive system showing the organs which are involved in 
gynecological cancers. It has recently been reported that ovarian epithelial tumors can be 
traced to the fallopian tubes and that this organ and not the ovary itself harbor the genesis 
of ovarian cancer.22 
Until the consensus statement released in 2007 by the American Cancer Society 
(ACS) detailing common symptoms that suggest the onset of the disease, it was widely 
accepted that any early signs of the disease were imperceptible. The symptoms include 
bloating, frequent urination, abdominal pain and fullness. All these signs are nonspecific 
and could indicate a host of other ailments such as irritable bowel syndrome. Hence, a 
woman with ovarian cancer may be diagnosed with a different ailment before learning 
that she has cancer which may be too late for life saving treatment. Studies show that the 
awareness of these symptoms is of very limited value in the early detection of the disease. 
In a large study by Rossing et at., involving 812 patients and 1313 control subjects, it was 
reported that the use ofthe symptoms detailed in the ACS consensus statement for 
ovarian cancer assessment is expected to result in the diagnosis of only lout of a 100 
women with the symptoms in the general population.23 
Some women are at a higher risk of developing the disease and would stand to 
benefit the most from accurate novel screening methods. The common risk factors 
include a family history of ovarian, breast or colon cancer, mutations in the BRCAI and 
BRCA2 genes, age over fifty, exposure to talc and mutations in the p53 tumor suppressor 
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gene and the HER2 oncogene. Women who have had close relations (sister, mother or 
daughter) developed the disease are at risk. The BRCAI and BRCA2 genes are tumor 
suppressors that in normal cells aid in stabilizing the cell's DNA and preventing 
uncontrolled cell growth. A harmful mutation in these genes put a woman at a huge risk 
of not only ovarian but breast cancer too. Lifetime risks for women in the general 
population is 14 out of 1000(1.4%) whilst that for those with the harmful BRCAI or 
BRCA2 mutation is 150-400 out of 1000 for developing ovarian cancer (15-40%)?4 Most 
ofthe ovarian cancer cases are found in postmenopausal women, usually after 50 years 
old with more than half of the cases developing in women 65 years or older. Advances in 
technologies that provide information about genetic risk factors have been made. These 
include genetic testing for finding mutations in the BRCAI and BRCA2 to determine a 
patient's risk of developing ovarian and breast cancers. The DNA chip technology is also 
available on the market for the detection ofthe p53 suppressor gene. Genetic testing, 
however, is expensive, takes a long time to get back results, and given the fact that it only 
gives information about the patients' risk of developing the disease, its usefulness is 
limited. 
Screening methods for ovarian cancer include transvaginal ultrasound (TVU), the 
CA-125 antigen test and pelvic exams. TVU is an imaging method that involves the 
probing of the vaginal cavity with a transducer to look for abnormalities on the organ. 
This method is useful in detecting tumors but can't differentiate between benign masses 
such as cysts and cancerous tumors. The CA-125 antigen test involves investigation of 
the levels of the CA-125 protein in the blood. High levels of the protein correlate with a 
high risk of the disease, but in a lot of cases, women without the disease have high CA-
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125 levels especially those in their child-bearing years, and some with average levels had 
already developed the disease. Furthermore, noncancerous diseases can increase CA-125 
in blood. Pelvic exams involve the insertion of a speculum to open the vaginal walls and 
a physical inspection of the reproductive organs. None of these methods has an 
acceptable performance for screening according to a National Institute of Health (NIH) 
consensus statement, and furthermore there is no evidence suggesting that even the 
combination of all three methods provide acceptable sensitivity and specificity. 
Positive significant impact in the cure of ovarian cancer lies in the development of 
better diagnostic tools than are currently available.25 Hence our interest in investigating 
optical spectroscopic techniques particularly fluorescence spectroscopy and well tailored 
multivariate statistical analysis (MV A) for ovarian cancer diagnosis. 
1.6.2 Cervical Cancer 
It is estimated that by the end of 20 1 0, the new cases for cervical cancer in the 
United States would climb to 12,200 and the fatalities from the disease would be at 
4,210.26 Worldwide estimates are staggering, with half a million women developing the 
disease and 250,000 women dying from it. The primary cause of the disease is the 
Human Papilloma Virus (HPV). It can be contracted through sexual contact and the 
different types ofHPV number in excess of 100. Out ofthis number, about 15 are cancer-
causing and 2 (HPV types 16 and 18) cause about 70% of the disease worldwide.27 Still, 
only a small percentage of women with HPV infection would go on to develop cervical 
cancer. The cervix is pictured as part of the female reproductive system in Figure 1.1 
above. With the introduction of the Pap smear procedure, the overall incidence and 
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mortality rate of the disease has dropped significantly reducing the mortality rate by 74% 
between 1992 and 1995. As the rate is still declining, it is the most successful cancer 
screening method in medical history. Yet the sensitivity of the Pap smear is very 10~8,29 
and a meta-analysis study found that it varies from 29%-56%.30 Improvement on the 
technology using a thin layer based method for sample preparation called ThinprepTM has 
been approved by the FDA.31 However, the additional expense that adopting this 
procedure would add to the cost of screening a patient is prohibitive and changes in the 
standard traditional procedure may not presently be warranted. During a Pap smear 
procedure, cells are taking from the cervix epithelium and examined under a light 
microscope to search for abnormalities that may indicate the presence of cervical 
precancer or cancer. An abnormal Pap smear, though, is usually the result of other factors 
beside the presence of cancer causing cells or HPV infection. These include vaginal 
infection, inflammation and other menopause related issues. When the result of a smear 
test is positive, a copolscopy, an examination of the cervix with a low powered 
microscope is usually done as a follow up to offer a complementary indication of disease 
presence. If the findings suggest abnormalities in the tissue, then a biopsy is performed to 
provide a more definitive diagnosis. A simple cervical biopsy referred to as punch biopsy 
involving the removal of a small tissue sample is the least invasive procedure. If 
warranted, a Loop Electrosurgical Excision Procedure (LEEP) which involves using a 
thin electrified wire operating at low voltage levels to remove tissue may be performed. 
Also if abnormalities are suspected inside the opening of the cervix, then endocervical 
biopsy involving the use of a curette to sample the organ is performed. And when severe 
abnormalities are detected, the more invasive cone biopsy is resorted to for removal of 
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tissues. This procedure entails the use of a scapel or carbondioxide laser to remove a 
cone-shaped sample of the tissue for further examination of cancerous cells. Irrespective 
ofthe effectiveness ofthe Pap smear, cervical cancer is the most common cancer, among 
women, besides that of the breast, and the most common of the gynecological cancers. 
New effective and cost-sensitive screening and diagnostic methods are needed ifthe 
estimated number of a quarter million worldwide fatalities is to be greatly affected. The 
diagnostic potential of optical detection methods make them good options to consider for 
the evaluation of cervical cancer. 
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lChapter 2: Materials and Methods-Fluorescence Spectroscopy 
2.1 Introduction 
This chapter gives a description of the methodology used in the measurement of the 
fluorescence spectra of the ovarian tissue samples. Details including the spectral 
measurements retained for further analysis (analysis presented Chapter 3) and tissue 
handling protocol is given. 
2.2 Measurements of EEMs of ovarian tissue 
Patients undergoing exploratory laparotomy or transabdominal endoscopy and 
oophorectomy at the Arizona Health Science Center of the University of Arizona were 
participated in this ex vivo spectroscopy study. The study was reviewed and approved by 
the Institutional Review Boards of the University. A table top spectroscopy system was 
used to collect fluorescence data from ovarian tissue ex vivo. The spectroscopy system 
consisted of a scanning fluorometer with double excitation and emission spectrographs 
(Fluorolog 3-22, JY Horiba, Edison, NJ) equipped with a custom fiber optic probe which 
was coupled to the spectrographs with a fiber optic adapter positioned in the sample 
chamber. The probe interrogated a spot of 800Jlm diameter. Emission spectra ranging 
from 290nm to 700nm at excitation wavelengths in the range 270nm to 550nm were 
measured each from 49 patients. These were assembled into Excitation-Emission-
Matrices (EEMs). An Excitation-Emission-Matrix (EEM) is a set of contour plots that 
show the intensity of tissues at various excitation and emission wavelengths. In this study, 
3 excitation wavelengths of 270nm, 300nm and 340nm were used for further analysis. At 
1 This work is adapted from Reference 32. 
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the time of surgery biopsies, typically 5xl0mm, were obtained from each ovary. Each 
biopsy was obtained from an area of interest selected by the surgeon. Corresponding 
ovary tissue was also taken for pathology. The tissue was rinsed with phosphate buffered 
saline (PBS) and placed on a biopsy tray under the fiber optic probe. The biopsies were 
placed in chilled RPM! culture medium (Mediatech Inc., Herndon, VA) to be transported 
to an optics laboratory for measurements. Each biopsy's fluorescence signal was 
collected at a sufficient amount of sites on the surface to cover the entire biopsy. The 
probe was positioned in contact with the surface epithelium. Each sample measurement 
took approximately 4 minutes and spectra were recorded from three or more locations on 
each biopsy. Optical signals were recorded within sixty minutes after removal. The 
system was calibrated with a set of positive and negative standards for purposes of 
wavelength and intensity calibration, as well as accurate background correction before 
every measurement. Deionized ultra filtered water served as negative standards, and 
positive standards were based on solutions of rhodamine, fluorescein and quinine. Data 
was reviewed by two experienced investigators. Samples were classified into four main 
groups: 1) Normal (no structures except stroma, epithelium corpus albicans and corpus 
luteum), 2) Benign neoplasm (abnormal growth without invasive areas), 3) Endometriosis 
(growth of endometrial glands and stroma on the ovary) or 4) Cancer ( invasive 
carcinoma into the ovary). For this study the cancer and normal groups were chosen for 
more detailed analysis since too few samples fell into either of the other two groups. The 
Cancer group has 25 samples (fluorescence spectra measurements) and the Normal group 
has 180 samples. 8 measurements were classified as benign neoplasm and 10 were 
classified as endometriosis. 
16 
lChapter 3: Support Vector Machine (SVM) via Neyman 
Pearson (NP) Classification of Ovarian Tissues 
3.1 Introduction 
Ovarian cancer is the deadliest gynecological cancer. The American Cancer 
Society estimates that for the year 2010, there would be 21,880 new cases of ovarian 
cancer and 13,850 deaths would result from the disease.33 It ranks fifth as the cause of 
cancer death in women and a woman has a 1 in 72 lifetime risk of developing the 
disease.34 Findings ofthe Surveillance, Epidemiology and End Results (SEER) Program 
of the National Cancer Institute suggest that the survival rate for ovarian cancer hasn't 
improved in 30 years since the 'war on cancer' was declared, whilst cancer affecting 
other again sites has significantly decreased mortality rates.33,34 Ovarian cancer is 
relatively hard to detect because currently there is no sound understanding of any 
preinvasive lesions. However, detection ofthe disease can be greatly improved by low 
cost technologies that can automate the diagnostic process and also increase the 
diagnostic accuracy. Fluorescence spectroscopy offers this opportunity. Moreover, the 
technique can relate tissue biochemistry and morphological properties to the spectrum. 
A large body of work has demonstrated that tissue classification based on 
fluorescence spectroscopy can be used for the diagnosis of cancerous tissues. It has been 
used extensively for the diagnosis or classification of cervical tissue dysplasia.35-38 
Gupta et aZ. obtained specificity and sensitivity, each greater than 99% for the in vitro 
1 This work is adapted from Reference 32. 
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discrimination between cancerous and benign/normal breast tissues.39 Scwharz et al. used 
the technique to diagnose oral cancer and dysplasia in vivo. The study involved both 
keratinized and non·keratizined tissues and they reported a sensitivity of 82% and a 
specificity of 87% for a relatively large independent validation set of 119 sites.4o Yang et 
al. found that in colon tissues, discrimination between adenocarcinoma and normal 
tissues yielded accuracy above 90% using intensity ratios involving excitation and 
emission wavelengths.41 In a study involving wavelengths from the UV A and UVB 
regions by Wang et a!., an algorithm using the ratio of integrated fluorescence intensities 
was used to distinguish ex vivo cancerous colorectal tissues from benign ones.42 Zaak et 
al. used an excimer laser operating at 308nm to probe bladder tissues of patients 
undergoing transurethral resection. They could diagnose bladder cancer with a sensitivity 
of95% and specificity of 77%.43 
Approaches to tissue optical spectra classification usually falls into two main 
groups: the model·based approach and the empiriCal approach. The model based 
approach, which provides a direct quantitative basis of the contributions of different 
tissue chromophores to a spectrum, uses biological and optical parameters extracted from 
physically·based models as features in classification algorithms. More recently, Redden· 
Webber et al. implemented physically·based models for both reflectance and 
fluorescence spectroscopy of the cervix and analyzed the data of330 patients.44 The 
combination of the two modalities into an adjoint algorithm yielded a sensitivity and 
specificity of 85% and 51 % respectively. Studies have especially been done on tissue 
classification using monte carlo models. For example, a monte carlo inverse model of 
diffuse reflectance was employed to classify the spectra of freshly excised breast tissues 
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into malignant or non-malignant groups. The classification was based on extracted 
features including hemoglobin saturation, total hemoglobin concentration, beta-carotene 
concentration and the reduced scattering coefficient.45 The empirical approach involves 
algorithms based on features directly selected from the raw spectrum or some 
transformation of the original data. A review of the literature suggests that in general, the 
latter produces better classification results than the former. Both approaches, but 
especially the empirical, rely heavily on the use of multivariate statistical analysis (MV A) 
methods. The most widely used methods for analysis or classification in tissue 
spectroscopy include Linear Discriminant Analysis(LDA),46,47 Artificial Neural 
Network(ANN)48 and K-Nearest Neighbors(kNN).49,50 Chandra et al. analyzed the 
measured fluorescence and reflectance spectra from pancreatic tissue and implemented an 
LDA algorithm based on the two modalities. Tissue fluorescence was excited at 355nm 
and the algorithm yielded a sensitivity of 85% and a specificity of 89% with negative and 
positive predictive values of 92% and 80% respectively. 51 Nayak et al. used ANN for 
classification involving oral malignancies. 52 Features were extracted from emission 
spectra obtained at 325nm of pulsed laser excitation and then fed into the algorithm to 
obtain a specificity and sensitivity of 100% and 96.5% respectively. Kamath et al. used a 
kNN based algorithm for differentiating, with high accuracy, colonic mucosal tissue 
fluorescence of a normal group from one comprised of malignant tissues. 50 
Analysis of ovarian tissue fluorescence spectra is scant in the literature, compared 
to that of the other organs cited above. Utzinger et al. has done exploratory studies to 
differentiate between the reflectance spectra of different ovarian tissue types, 53 and 
Brewer et al. has explored fluorescence spectroscopy and microscopy of the ovary.54,55 
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Kamath et al. used fluorescence excitation at the single wavelength of 325nm, and MY A 
to distinguish the spectra of ovarian tissues,49 and more recently Tanbakucki et al. 
developed a confocal microlaparoscope designed for real-time imaging of the ovarian 
epithelium. 56 Also, the use of wavelengths below 300nm for the excitation of tissue 
fluorescence is relatively uncommon despite studies showing that it is safe at low 
excitation power. 
In this study, we analyze the fluorescence spectra of excised normal and 
cancerous ovarian tissues at multiple excitation wavelengths and use the spectral data for 
binary classification. The data includes spectra obtained at the UVC wavelength of 
270nm, the UVB wavelength of 300nm and at 340nm, an often useful diagnostic 
wavelength. The first wavelength has been rarely examined for diagnostic significance. 
We used both the sensitivity/specificity/accuracy metric and the Area Under Curve (AUC) 
to assess diagnostic performance rather than just relying on one metric. We obtained 
comparable classification results for all of the 3 excitation wavelengths for discrimination 
between cancer and normal tissues (cancer vs. normal) and for discrimination between 
cancer and noncancerous tissues (cancer vs. noncancer). We introduce the application of 
a novel SVM algorithm for binary classification of fluorescence data. This SVM is 
trained subject to the Neyman-Pearson (NP) criterion, in which we find a decision rule 
that maximizes the specificity while constraining the sensitivity to be a high value. 
Traditionalleaming approaches involve seeking a decision that maximizes the overall 
accuracy rather than either the sensitivity or specificity. By modulating the threshold, we 
can selectively train for either high specificity or sensitivity values rather than the overall 
accuracy. This flexibility in algorithm development makes it attractive as an adjunct 
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modality to already existing screening methods such as the conventional ultrasound 
which routinely yields low positive predictive values for the screening of ovarian cancer. 
Also this learning approach may be able to improve the performance of currently 
available optical spectroscopic diagnostic tools on the market. Moreover, this algorithm 
is especially suitable for dealing with unbalanced data involving one group having a far 
larger size than the other. Unbalanced data has a tendency of biasing an algorithm's 
performance towards the group with the larger size. Zhu et al. underscored this problem 
in their breast tissue fluorescence study, in which an SVM was used in classification 
involving 27 malignant and 94 nonmalignant tissue samples.57 They concluded that the 
lower sensitivity compared to the specificity their SVM algorithm yielded, was likely due 
to the unbalanced data set. A review of the literature suggests that it is very common for 
studies to have unbalanced data set in which the control/normal group has a relatively 
larger size or a far larger size than the disease group. The data in this study is no 
exception with 25 members in the cancer group versus 180 in the normal group and 198 
in the noncancer group. This algorithm that trains data subject to the NP criterion, may be 
more suitable than traditional ones in the training and classification of unbalanced 
datasets. Also, we analyze the data with dimension reduction methods principal 
component analysis (peA) and partial least squares (PLS) and use PLS to reduce the 
feature size required for training. 
3.2 SVM in Optical Spectroscopy 
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Algorithms based on SVM have been successfully used for the classification of 
optical spectroscopic and other types of medical data.57-6o In the field of fluorescence 
spectroscopy, a study employed a linear kernel SVM in grouping breast tissues into 
malignant and nonmalignant groups. 58 The SVM inputs were based on features extracted 
from a montecarlo model of fluorescence and diffused reflectance. Different 
combinations of the extracted parameters including hemoglobin saturation, reduced 
scattering coefficient, and the relative concentration of individual flourophores were used 
as inputs into the SVM algorithm to yield different classifiers, some of which produced 
classification accuracies of greater than 86%. Palmer et aZ. used a similar montecarlo 
model to extract features for an SVM algorithm that yielded a sensitivity and specificity 
of 82% and 92%, respectively. 59 Only two features, the hemoglobin saturation and the 
reduced scattering coefficient were used as input parameters and the dataset involved 17 
histopathologicaly malignant and 24 normallbenign ex vivo breast tissues. In a study by 
Majumder et aZ., a recursive feature selection was integrated into an SVM algorithm, for 
the purpose of reducing the dimension of the feature space, to train oral spectroscopic 
data. This integrated algorithm was tested on an independent data set to yield a sensitivity 
and specificity of93% and 97% respectively.6o They noted that this outperformed a 
Fisher's Linear Discriminant algorithm tested on the same data. Further studies have 
confirmed the superiority of SVM over algorithms in learning data. For the classification 
of PET brain images, an SVM improved on the performance ofa neural network(NN) 
yielding an error rate of 7.1 % compared to 14.3% for the NN.61 
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3.3 Algorithm 
3.3.1 General Binary Classification 
In binary classification algorithms, a general rule from an input data sample that 
also holds true for new data is sought. The given data can be formalized as S = {(Xi> Yt) I 
Xt E IRP, Yt E {-1, +1}} }n, xi> the feature vector, is a vector of the data points for the i-th 
data sample, for example in the case of discrimination using the spectral data, it 
corresponds to the intensity values that make up the fluorescence emission spectrum. p is 
the feature size, n is the total sample size and Yt is the data label that can assume either of 
two values + 1 or -1. The aim is to find a function f: IRP --+ {-1, + 1} that predicts 
accurately the label of any new input data sample (feature vector). For example, in the 
case for classification of input data into cancer and normal groups, we use Yt E -1 for 
any sample data belonging to the normal (control group) and Yt E +1 is for samples 
belonging to the cancer group. The sensitivity, specificity and accuracy used for 
evaluating the binary classifier are defined as follow: 
TP TP 
Sensitivity = p = TP + FN 
TN TN 
Specificity = Ii' = TN + FP 
TP+TN 
Accuracy = P + N 
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TP or true positive is the number of positive samples correctly classified; TN or true 
negative is the number of negative samples correctly classified; FP or false positive is the 
number of negative samples that are misclassified as positive; FN is the number of 
positive samples that are misclassified as negative; P denotes the total number of positive 
samples; N denotes the total number of negative samples. 
3.3.2 SVM Formulation 
SVM classification involves the mapping of the original input data, Xi into a 
higher dimensional feature space, H, by the transformation tP: liP -+ H, and then 
constructing a maximum margin hyperplane to separate the data into 2 classes (groups). 
The formulation, as detailed later in this section, involves the inner products of the 
vectors in feature space. But in using kernel functions k( Xi, Xj), with k( Xi, Xj) = 
(tP(Xi), tP(Xj), we can actually sidestep the explicit evaluation of the mapping tP : 
liP -+ H and still evaluate the inner products. Partitioning of the data should be easier 
even allowing for the linear separation of data that would be linearly inseparable in lip. 
tP(Xi) k(Xi,Xj) 
Polynomial of degree d (Xi.Xj + b) d 
Radial basis function (1I xt-x/II 2 ) 
e 20'Z 
Sigmoid tanh(axioXj - b) 
Table 3.1- list of widely used SVM kernel functions. 
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Some of the most widely used kernel functions are listed in Table 3.1 above. In this study 
we chose the widely used RBF kernel for classification. The decision boundary is a linear 
combination of supporting vectors which are simply a subset of the training vectors with 
the closest proximity to the boundary. The advantages of SVMs over other conventional 
classification methods include the ability to use different kernel functions, ability to 
provide a global optimal solution and very high generalization ability owing to its basis 
of interclass margin maximization. Also one only has to pick few model parameters 
making training easy and the final classifier is stable and gives reproducible results. 
Barring numerical issues if the same SVM model, with the same parameters is used to 
classify a particular dataset multiple times, the solution would be the same. 
In the traditional SVM, the C-SVM, the maximum margin hyperplane solves the 
quadratic program statement: 
(1) 
s.t fOT i = 1, ...... n 
fOT i = 1, ... ... n 
with C ~ 0 controlling overfitting 
A large C implies a high penalty for misclassification, f is a slack variable and it allows 
for misclassification of some of the training data, which is critical for unseparable data. 
C controls the tradeoff between the slack variable and the size of the margin; w is the 
normal vector and b is the bias that describes the discriminating hyperplane. An 
equivalent formulation known as the v-SVM was introduced to further clarify the 
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meaning of the penalty parameter, C. In this formulation, C is replaced with the 
parameter, v E [0,1]. This parameter is the upper bound on the fraction of support vectors 
and the lower bound on the fraction of margin errors. The primal problem for the v-SVM 
is: 
(2) 
s.t for i = 1, ... ... n 
and fi ~ 0 for i = 1, ... ... n 
and p ~ 0 
During training, v is user supplied and p is optimized. C in the primal formulation is 
also user supplied. 
The C-SVM and its corresponding v-SVM formulation however only allow for 
the same weights on either group and hence proves to be unsuitable for problems that 
have unbalanced datasets. For binary classification problems, data imbalance results 
when the group size is much greater in one group compared to the other. The incidence 
rate of ovarian cancer among women at 12.9 per 10000 women is low as is the incidence 
rate of many diseases. Designing and conducting a clinical study involving the 
fluorescence spectra of patients come at the expense of money and time. Ideally 
investigators would like to use as much of the collected data from as many of the patients 
as possible for training a diagnostic algorithm. It is inevitable that recruiting patients for 
control data is easier than for cancer data and that the total sample size used for training 
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the algorithm would be tilted towards the control data. For this study, we have 180 
normal and 198 noncancer samples each versus 25 cancer samples. 
Cost sensitive SVMs which allow for different weights to be given to different 
classes have been formulated. The 2C-SVM and 2v-SVM have been proposed as the cost 
sensitive extensions for the C-SVM and v-SVM respectively. 
LetI+ = {i:Yi = +l}andL = {i:Yi = -1}The2C-SVMhasprimalformulation: 
(3) min(w,b,{) i II w 112 + Cy LiE/+ fi + C(l - y) LiEf- fi 
s.t for i = 1, ... ... n 
for i = 1, ... ... n 
and dual: 
(4) 
s.t for i E 1+ 
o ~ ai ~ C(l - y) fori E L 
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Where C, as mentioned previously controls overfitting and Y E [0,1] adjusts the 
tradeoff between the 2 error types and hence the sensitivity and specificity. 
The 2v-SVM has primal formulation: 
(5) 
s.t 
and dual 
(6) 
. ( b ~ ) 1 // //2 Y l-y mm w, ,~, p '2 w - vp + ;; LiEl+ {i + -;;-LiEL {i 
s.t 
and p ~ 0 
l-y O<a·<-
- l- n 
fori = 1, ...... n 
fori = 1, ...... n 
fori E 1+ 
fori E L 
where v E [0,1] controls overfitting and y E [0, 1] is a parameter that allows for trade 
of between the two error types and hence permits the adjustment of the sensitivity and 
specificity values. Hence the SVM application for the diagnosis of fluorescence spectra 
detailed in this study has 3 main advantages over the use of traditional SVMs reported in 
the literature. The algorithm can account for difference in group size and this makes it 
more appropriate for use in screening or diagnosis, the Neyman Pearson criterion allows 
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for us to set a high sensitivity value while training to maximize the specificity, and the 
user specified parameter is bounded and hence renders the algorithm far less arbitrary 
since the beginning and end points don't have to be chosen subjectively. 
3.3.3 Neyman Pearson (NP) 
In our usage of the NP classification paradigm, the aim is to find a decision rule 
that maximizes the specificity whilst maintaining the constraint that the sensitivity be at 
least equal to a desired user specified significance level, a. 
The NP criterion then in terms of specificity and sensitivity is: 
f:P = f:se::;~ivitYm'::a specificityCf)· So the SVM classification was performed 
subject to the NP criterion stated above. And this allows us to set an acceptable limit to 
the sensitivity whilst seeking the maximum specificity. 62-64 Further details about the NP 
algorithm is in Davenport et al. 62 and Scott et al. 63 For the NP training, a grid search over 
parameters (v +, V _,0) for the SVM RBF kernel was performed. Leave-one-out cross 
validated estimates of sensitivityCf) and specificityCf) were calculated and the 
parameter combination that maximizes specificity(f) subject to sensitivity (f) ?: a 
was sought. The highest specificity on the receiver operating characteristic (ROC) curve 
which fulfilled the NP criterion and its corresponding sensitivity were selected as the 
representative specificity and sensitivity respectively and reported in Section 3.5. The 
Area Under Curve (AUC) is also reported. The SVM parameter space for training is: for 
the bandwidth parameter, (f could assume values of 100 logarithmic space points 
between 10-10 and 1010, and (v+, v_) E [0,1] x [0,1]. In this study we were interested 
in ensuring that the sensitivity is high and so we set the threshold accordingly and the 
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SVM training was subjected to the classifier, f~p. We wanted to train for the correct 
classification of at least 22 out of the 25 cancer samples (sensitivity of88%), using the 
spectral data as features, and hence a was set to a value of 0.88. This a value produced 
stable classification results. For the classification involving the PLS components, a = 0.8 
was desired. It provided good results that were also stable. We could also just as easily 
constrain the specificity to be above a desired value and train to maximize the sensitivity 
instead. 
3.4 Analysis methods 
3.4.1 Principal Component Analysis (PCA) and Partial Least Squares 
(PLS) 
Principal component analysis is a technique that transforms a given dataset 
composed of possibly correlated variables into a smaller number of un correlated 
variables, the principal components (PCs), and can reveal underlying dynamics in the 
dataset. The transformed data is expressed as the component scores. The first PC 
accounts for as much variability as possible in the dataset, and each subsequent PC 
accounts for as much of the remaining variability as possible. Hence, the dataset can be 
described by the first few PCs while the higher order PCs are usually uninformative and 
are due to noise. It is a true eigenvalue method, a widely used technique for dimensional 
reduction and has been applied to fluorescence spectroscopic data in numerous 
studies.49,5o Partial Least Squares (PLS), another widely used method in optical 
spectroscopy,45,65,66 is a regression method for dimension reduction, which in the 
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transformation of the dataset also takes into consideration the response variable (labels). 
In this case unlike in PCA, the construction of the PLS components (also referred to as 
PLS-C in this chapter) is done in such a manner that there is high covariance between the 
spectral variables and the corresponding labels.67 This limits the impact of large 
variations in the dataset that may nonetheless be irrelevant in the classification algorithm. 
Detailed description ofthe PLS regression process is found in Geladi et al .. 68 In this 
study, we used PLS to reduce the dimension of the fluorescence data matrix and utilized 
the transformed PLS scores for differentiating the spectra of cancer and normal tissues of 
the ovary. It was also applied for the discrimination between cancer and noncancer 
tissues. Some of the PCs from the PCA analysis were used to visualize the data in 
component space. Being an unsupervised method, we may be able to visualize the 
transformed data without an imposition of the labels. The main reason for our use ofPLS 
is to obtain acceptable results with a smaller feature size. 
3.4.2 Selection of Components 
The PLS components (PLS-Cs) that contributed to 99% ofthe total variance were 
selected as inputs to the wilcoxon ranksum test. The test is a nonparametric hypothesis 
test for the assessment of two independent observation samples. The component selection 
process is similar to that of other spectroscopic studies.45,66 The PLS-Cs that showed 
statistically significant differences between the two groups at the significance value of (p 
<0.05) were then chosen as having diagnostic value and hence used as attributes in the 
SVM classification. 
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3.4.3 Cross-validation 
The idea of cross-validation is employed in testing classifiers when there are not 
enough samples to divide the dataset into a training/calibration set and a testing set. The 
premise is that the predictive ability of a model formed on part of a data (training set) can 
be tested out by how well it predicts the remainder of the data.69 The idea of cross-
validation involves dividing a dataset into p subsets and using p -1 subsets to build a 
statistical model and testing this model on the left out subset. A total of p different 
models are built, each model excluding a unique subset (containing samples not included 
in training the model) to be tested. A commonly used method of cross-validation is the 
leave one out cross-validation procedure. This involves building the model on all but one 
of the samples and using the resultant model to test out only the left out sample. In other 
words, the left out subset just contains one sample. This procedure is a method for 
assessing a model's performance70,71 and was used in the determination of the 
generalization error of the SVM classifier. The proportions of the classification showing 
true positive and true negative results were used to calculate the sensitivity and 
specificity respectively. The classification accuracy was calculated as the proportion of 
the entire dataset accurately classified into their true groups. 
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-3.5 Results 
The raw bulk fluorescence spectra of all the measurements (involving the cancer 
and normal groups) are plotted in Figure 3.1. In Figure 3.1(a), the emission spectra ofthe 
tissues at 270nm excitation is shown and the wavelength range retained for classification 
is 290-515nm (46 spectral variables). Figure 3.1(b) shows spectra measurements at 
300nm excitation. The emission wavelength range of 320-570nm is retained for 
classification (51 variables). Figure 3.1(c) shows the spectra measurements at 340nm of 
excitation which had the wavelength range of 360-640nm retained for classification (57 
variables). It is clear from the figures that there is considerable variation in the intensities 
of the measured signals. In some cases the intrapatient variations exceed the interpatient 
variations which underscore the need for spectra preprocessing. The preprocessing 
involved normalization of each measurement to its peak emission intensity. Preprocessed 
fluorescence spectroscopic data was used as input features for the SVM classification as 
depicted in Figure 3.2, the algorithm flowchart. The bulk fluorescence spectra is a data 
matrix consisting ofthe emission spectra for all the measurements in both classification 
groups for each excitation wavelength. The cancer group size was 25 and the normal 
group size was 180. 
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Figure 3.1- Fluorescence emission spectra of all the cancer and normal spectra used in 
classification. Excitation wavelength is at (a) 270nm, (b) 300nm and (c) 340nm. Cancer 
group has 25 and normal group has 180 measurements. 
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Figure 3.2- Flow chart of the classification algorithm development for the problem of 
discriminating between cancer and normal groups (cancer vs. normal). 
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Figure 3.3- Variance plot for cancer vs. normal discrimination at 270nm excitation: Plot 
of the total percentage variance explained in the spectral dataset obtained at 270nm 
excitation for discrimination between cancer and normal groups. The total percentage 
variance in the original spectral data is shown as a function of PLS and PCA components. 
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Figure 3.4- Variance plot for cancer vs. normal discrimination at 300nm excitation: Plot 
of the total percentage variance explained in the spectral dataset obtained at 300nm 
excitation for discrimination between cancer and normal groups. The total percentage 
variance in the original spectral data is shown as a function of PLS and PCA components. 
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Figure 3.5- Variance plot for cancer vs. normal discrimination at 340nm excitation: Plot 
of the total percentage variance explained in the spectral dataset obtained at 340nm 
excitation for discrimination between cancer and normal groups. The total percentage 
variance in the original spectral data is shown as a function of PLS and PCA components. 
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Figure 3.6- Variance plot for cancer vs. noncancer discrimination at 270nm excitation: 
Plot of the total percentage variance explained in the spectral dataset obtained at 270nm 
excitation for discrimination between cancer and noncancer groups. The total percentage 
variance in the original spectral data is shown as a function of PLS and PCA components. 
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Figure 3.7- Variance plot for cancer vs. noncancer discrimination at 300nm excitation: 
Plot of the total percentage variance explained in the spectral dataset obtained at 300nm 
excitation for discrimination between cancer and noncancer groups. The total percentage 
variance in the original spectral data is shown as a function of PLS and PCA components. 
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Figure 3.8- Variance plot for cancer vs. noncancer discrimination at 340nm excitation: 
Plot of the total percentage variance explained in the spectral dataset obtained at 340nm 
excitation for discrimination between cancer and noncancer groups. The total percentage 
variance in the original spectral data is shown as a function of PLS and PCA components. 
For 270nm of excitation, the data matrix size from the spectral dataset 
was (205x46) i.e. consisting of205 feature vectors (measurements) and 46 attributes 
(emission intensity data points). The specificity was 93.3% and the sensitivity was 96% 
with an AUC of 0.986 for discriminating between cancer and normal groups. Also 
attributes composed of the scores of the PLS components were used as input features to 
the SVM for classification. As noted in Section 3.4.1, PLS is a data compression method 
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which seek significant variations within the entire spectral data set that also have 
maximum covariance with the labels and then delineates the data set as a small set of 
component spectra or PLS components (PLS-C) and corresponding scores. PLS was 
applied to the fluorescence spectroscopic data. The components that contributed to 99% 
of the total variance in the dataset were selected and the wilcoxon rank test was used to 
determine which of these had scores that showed statistically significant differences 
between the two groups for the classification problems, cancer vs. normal and cancer vs. 
noncancer. The PLS-Cs that had scores which showed statistically significant differences 
(p < 0.05) were used as input features for the SVM classification. Figures 3.3-3.8 shows 
plots of total variance in the spectral data accounted for by the PLS and PCA components 
for each of the classifiers. In the variance plots, the contributions of the PLS-Cs and PCs 
to the total variance in the data are plotted against the factor numbers or the PC numbers. 
So the notation is: factor number l, ... n is PCI, ... PCn for PCA components and PLS-
C I, .... PLS-Cn for PLS components. It can be observed that for each wavelength, in 
general the first few PLS-Cs had huge contributions to the amount of variance in the data 
while the higher order PCS contribute very little. Also, generally, the total percentage 
variance explained in the spectral data is higher for the PCA components compared to the 
PLS components. This may be due to the fact that PCA seeks variations without regard to 
the labels while PLS seeks variations that have covariance with the labels. Tables 3.2 and 
3.3 show the PLS components that have statistically significant differences for the cancer 
vs. normal and cancer vs. noncancer discrimination problems respectively. As shown in 
Table 3.2, at the significance level ofp < 0.05, PLS-C2 (p=.047) and PLS-C4 (p=0.03) 
were statistically significant. At p<0.005, PLS-CI (p=0.004) and at p < 0.0005, PLS-C3 
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(p=3.4xlO-S) exhibited statistically significant differences for discrimination at 270nm 
excitation. Tables 3.4 and 3.5 show the classification results for when the spectral 
variables were used as input to the classification algorithm. It can be observed that the 
classification results for 270nm excitation is competitive with the results at the other 
wavelengths. Classification results based on the PLS-C feature set (PLS-Cl, PLS-C2, 
PLS-C3, PLS-C4) yielded a specificity of90.6% and a sensitivity 88% as shown in Table 
3.6. This shows that good classification could be obtained from a reduced feature size of 
only 4 attributes. 
Wavelength P-Value 
P <0.05 P<0.005 P<0.0005 
270 PLS-C2,PLS-C4 PLS-Cl PLS-C3 
300 PLS-C2,PLS-C4 PLS-C 1 ,PLS-C3 
340 PLS-C3 PLS-C2 
Table 3.2- This shows the PLS components (PLS-Cs) that have statistically significant 
differences for discrimination between the cancer and normal groups. 
Wavelength P-Value 
P <0.05 P<0.005 P<0.0005 
270 PLS-C2 PLS-Cl, PLS-C4 PLS-C3 
300 PLS-C2,PLS-C4 PLS-C 1 ,PLS-C3 
340 PLS-C2 
Table 3.3- This shows the PLS components (PLS-Cs) that have statistically significant 
differences for discrimination between the cancer and noncancer groups. 
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Wavelength Classification results 
Sensitivity Specificity Accuracy AVC 
270 96 93.3 93.7 0.986 
300 100 93.9 94.6 0.981 
340 96 99.4 99 0.984 
Table 3.4- This shows the SVM classification performance for cancer vs. normal wIth the 
spectral data as features. 
Wavelength Classification results 
Sensitivity Specificity Accuracy AVC 
270 96 93.3 93.7 0.986 
300 96 92.78 93.17 0.962 
340 88 90 89.77 0.921 
Table 3.5- ThIS shows the SVM claSSIficatIon performance for cancer vs. noncancer with 
the spectral data as features. 
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Wavelength Classification results using PLS-Cs as features 
Cancer vs. Normal Cancer vs. Noncancer 
Sensitivity Specificity Accuracy AUC Sensitivity Specificity Accuracy AUC 
270 88 90.6 90.2 0.921 88 90.0 89.76 0.916 
300 88 93.9 93.2 0.910 84 88.9 88.29 0.87 
340 88 97.8 96.6 0.930 80 81.1 81 0.833 
Table 3.6- Classification results of the SVM tramed on the PLS components (PLS-Cs) 
showing statistically significant differences for the two classification tasks: cancer vs. 
normal and cancer vs. noncancer. 
Figure 3.9 depicts examples of 2-d plots of principal components. There is some 
obvious demarcation between the scores of the 2 groups in this simple plot for each 
wavelength, even though it is not possible to find any single line to clearly separate the 2 
groups. The fact that the unsupervised PCA method shows some discrimination between 
the groups may give an indication of the usefulness of supervised learning methods 
which use the labels of the training data in constructing the classifier. This calls to 
attention the usefulness of SVMs which allow the data space (involving the PCs) to be 
transformed into a higher dimensional feature space and a hyperplane sought to better 
distinguish the two groups. Figure 3.10 shows the ROC curves for the cancer vs. normal 
discrimination using the spectral data as SVM inputs. The AVC values are all greater 
than 0.9. 
At 300nm excitation, the data matrix size from the spectral dataset was (205x51) 
and when it was used as the original input space for the SVM, the specificity obtained 
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was 93.9% and the sensitivity was 100% with a ROC AUC of 0.981 for discriminating 
between cancer and normal tissues as shown in Table 3.4. Figure 3.4 shows that when 
PLS and PCA were applied, the first 3 components yielded about 99% of the variance 
and each yielded statistically significant differences between the cancer and normal 
groups. Figure 3.1(b) suggests, the spectra of the cancer and normal groups have similar 
intensity values. When the peak emission intensity values were compared, there wasn't 
any significant difference between the normal and cancer groups at the significance level 
ofp<O.OS. Classification results based on the PLS component feature set yielded a 
specificity and sensitivity of 93 .9% and 88% respectively. 
At 340nm excitation, the data matrix size from the spectral dataset is (20SxS7) 
and the results of the trained SVM for discrimination for cancer vs. normal are tabulated 
in Table 3.4. It should be noted that even though the accuracy of 99% is higher than that 
for 270nm which is 93.7%, the AUC of 0.984 is slightly less than the AUC for 270nm 
excitation which is 0.986. In the literature, the overwhelming majority of studies report 
either the AUC or the specificity/sensitivity/accuracy for the evaluation of an algorithm. 
When the goal is to compare the performance of algorithms, providing both metrics may 
be more useful than just using either one in the evaluation process. 
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Figure 3.9- Score plots of principal components for the discrimination of cancer and 
normal groups. Topmost graph is that of PC 1 and PC3 for 270nm excitation. Middle plot 
is that of PC 1 and PC2 for 300nm excitation. Bottom plot is that of PC 1 and PC2 for 
340nm excitation. 
F or the cancer vs. noncancer discrimination, the data matrix for each excitation 
wavelength had a length of 223 corresponding to the total number of measurements. This 
noncancer group was composed of the data from benign neoplasm (8 measurements) and 
endometriosis (10 measurements) in addition to the measurements from the normal group. 
Endometriosis is a painful condition in which tissue similar to the endometrial layer 
lining the uterus is found on the ovary, and benign neoplasms are tumors that are not 
malignant and are unlikely to tum into cancer. The variance plots for each of the 
classifiers for the cancer vs. noncancer discrimination is provided (Figures 3.6-3.8). It is 
obvious from the plots that the first few components are responsible for the most 
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variation in the dataset. Similar to the cancer vs. normal case, the PLS components 
explain less of the variance in the spectral dataset compared to the PCA components. 
Table 3.3 summarizes the PLS-Cs that showed statistically significant differences 
between the two groups. All the PLS-Cs that exhibited statistically significant differences 
for the comparison between the cancer and noncancer groups were also statistically 
significant for the comparison between the cancer and normal groups. For the 
classification at 340nm excitation, only one PLS-C showed statistically significant 
difference for significance levels ofp <0.05. But, the SVM algorithm requires at least 
two features for classification; a significance level of 15% (p <.15) was able to select the 
needed feature size and hence was used. PLS-C 1 and PLS-C2 were selected to be used 
for the cancer vs. noncancer discrimination. Table 3.6 summarizes the classification 
results using the PLS-Cs selected by the wilcoxon test, and it showed generally good 
values for AVC and specificity/sensitivity/accuracy. The cancer vs. noncancer 
classification followed the same process as outlined in the flowchart of Figure 3.2, the 
only difference being that the "Normal Scores" is replaced by "Noncancer Scores". 
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Figure 3.10- This shows the ROC curve for discrimination between cancer and normal 
groups when the SVM was trained on the spectral data, and when the SVM was trained 
on diagnostically relevant PLS-Cs. Results are shown for: (a)270nm, (b)300nm and 
(c )340nm of excitation. 
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3.6 Discussion 
Limited work has been done on ovarian fluorescence spectroscopy, as compared 
to other organ sites. Brewer et al. has explored fluorescence spectroscopy and 
microscopy of the ovary. 54,55 Kamath et al. reported the multivariate analysis of ovarian 
tissue fluorescence spectra in which they studied tissues in three main histopathological 
groups: cancer, normal and benign. Features including the mean, median, spectra residual 
and standard deviation of the emission spectra were used as inputs into a kNN algorithm 
for classification.49 They were able to obtain a specificity of 100% and a sensitivity of 
90.9% for classification. Whilst this study has great results, they used a small data set 
involving only 20 patients and a total of97 measurements with only one wavelength of 
325nm. The data set employed in our study is more than twice the size of that used in the 
aforementioned study and we analyzed data at multiple excitation wavelengths. 
The average emission peak for the tissues at 270nm of excitation occurs at around 
325nm emission, indicating the presence of tryptophan residues with some contribution 
from the other aromatic acids phenylalanine and tyrosine. The most dominant 
fluorophore excited at this wavelength is tryptophan, and there is regular energy transfer 
from tyrosine to tryptophan. There is an observed increase in the fluorescence emission 
peak in the cancer group relative to the normal group as shown in Figure 3.1(a). This may 
be attributed to an increase in the concentration of the aforementioned fluorophores. Even 
other spectroscopy modalities besides fluorescence, suggest that these aromatic amino 
acids have varying contributions to a spectrum depending on tissue histopathology. For 
example a Raman spectroscopy study by Draga et al. reported statistically significant 
differences (at least p< 0.01) between cancer and normal tissues at infrared wavelengths 
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that were attributed to phenylalanine ( 1003cm-1 and 1208cm-I ), tyrosine (1170cm-l ) and 
tryptophan (1208 cm-I ).72 Other studies involving other tissue organs have also observed 
this change.73 The great classification results we obtained from the spectroscopic studies 
suggest the usefulness of270nm excitation for fluorescence imaging applications since 
the technique relies on spectrally selective excitation and emission wavelengths. A 
diagnostically relevant excitation wavelength is crucial in this application which enables 
the imaging oflarge areas of tissue. One can easily use a band pass filter selecting 
wavelengths around the peak emission maxima of the spectrum to collect the 
fluorescence images of tissues. And the of the high sensitivity and specificity SVM 
algorithm, automated diagnosis of cancer and even precancer tissues that have known 
precancerous lesions can be realized. 
At 300nm of excitation, the average emission peak of the spectra shown in Figure 
3.1(b) occurs at around 315nm. It is likely that tyrosine fluorescence contributes to the 
peak just as it did for 270nm excitation. The emission peak intensity didn't show 
statistically significant differences between the two groups as it did for 270nm excitation. 
It has been reported that unlike for the DVe wavelength, tyrosine and phenylalanine may 
not be excited at 300nm.73,74 Hence it is possible that the lack of contribution from 
tyrosine and phenylalanine to the spectra is partly responsible for the small peak intensity 
difference between the two groups. Nonetheless we noted higher average peak intensity 
in cancerous compared to normal tissues and this observation is made in other studies as 
well. In a seminal study by Yang et al., the spectra of excised cancerous tissues showed 
higher fluorescence intensity at an emission peak of 340nm than normal tissue for 300nm 
excitation.41 
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The emission spectrum for 340nm of excitation has average peak emission at 
390nm and a less prominent peak at 460nm as observed in Figure 3.I(c). Also there is a 
prominent dip at around 430nm of emission which is attributed to oxyhemoglobin 
absorption in the tissue. The measured spectra was different for the cancer and normal 
groups. As measured by the wilcoxon ranksum test, there was a statistically significant 
difference between cancer and normal groups at the emission peak of 390nm (p < 4.5 x 
10.4 ). It was observed that as the wavelength of excitation increases, the average peak 
emission fluorescence of normal tissues get larger than that of cancer tissues. This may 
suggest that some ofthe prominent fluorophores that get excited at longer wavelengths 
have smaller concentrations in cancer tissues. Studies conducted using excitation around 
the 340nm wavelength, include one by Ramanujam et at. in which a 337 nitrogen laser 
was used to acquire the spectra of preneoplastic, neoplastic and normal tissues of the 
cervix.75 They noted a decrease in the fluorescence signal of tissues with the progression 
of cancer. This was attributed to a decrease in collagen fluorescence and an increase in 
oxyhemoglobin attenuation, among other factors. Another study at the same wavelength 
of excitation was used to analyze spectra from colon sites of patients. Also in this study, 
spectroscopic differences were observed between the spectra of neoplastic and non-
neoplastic tissues and a diagnostic algorithm exploiting the differences, obtained a 
sensitivity and specificity of 80% and 92% respectively for distinguishing between the 
two tissue types.76 Georgakoudi et at. combined the techniques of fluorescence and 
diffuse reflectance spectroscopy to extract the intrinsic NAD(P)H and collagen 
fluorescence from bulk Barrett's esophagus tissue fluorescence in vivo. 77 They found that 
the intrinsic NAD(P)H fluorescence was substantially smaller and intrinsic collagen 
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fluorescence greater in non-dysplastic tissues compared to dysplastic tissues thus 
shedding light on the biological basis of the spectral differences that occur at around 
340nm excitation. Findings from other studies also suggest an increase in NADH 
fluorescence with dysplasia.36-39 The reason that can be attributed to the increase in the 
NADH metabolic coenzyme in cancerous tissues is the higher metabolic activity in these 
tissues. The presence of the protein, collagen also contributes to the fluorescence at this 
wavelength. A breakdown of the extracellular matrix of ovarian tissue as cancer develops 
is responsible for the marked decrease in collagen fluorescence which has an emission 
maximum close to the average emission peak of 390nm observed in this report. With a 
sensitivity of 96% and a specificity of 99.4% for the discrimination of cancerous tissue 
spectra from normal spectra excited at 340nm, this wavelength is very useful for 
classification of ovarian tissues. Tissue excitation around this wavelength range is very 
common in the literature as many studies involving multiple excitation wavelengths have 
found that it usually is among the most significant tissue classification wavelengths.38 
Concerns for patient safety and possible tissue mutagenicity after exposure to UV 
radiation are among the reasons that UVC wavelengths are underutilized for tissue 
spectroscopy or imaging. But it has been shown that successful studies can be conducted 
for excitation at low power levels that are safe.54,78-80 Safety standards for skin exposure 
as established by the American Conference of Governmental Industrial Hygienists 
(ACGIH) puts a maximum threshold limit of radiation from broadband sources in the 
range 250-400nm at .003J/cm2. 81 Spectroscopy systems for the detection of cervical 
cancer submitted to the FDA for approval are expected to have radiation thresholds 
below the limit set by the ACGIH.81 Tissue fluorescence spectra with high signal to noise 
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ratio can be obtained at levels up to an order of magnitude below this threshold.82 As 
safety issues can be held in check, the excellent diagnostic potential ofthe vve region 
makes wavelengths in that range warrant further studies. The FDA has approved a 
number of optical systems for use in tissue diagnosis.83,84 One such system, the 
WaVSTAT developed by SpectraScience and approved as an adjunctive tool to aid in 
colon cancer diagnosis uses laser excitation in the UV to collect fluorescence spectra to 
provide immediate classification of tissue into normal, precancer or cancer groups. It has 
been noted that while endoscopy in expert hands may achieve a sensitivity of 80% for 
disease detection, WaVSTAT can achieve a sensitivity of96%.85 But then the system has 
a fairly low specificity of about 75% which results in significant number of false 
positives.85 The SVM algorithm outlined here may be used in such a system to achieve an 
acceptable specificity whilst maintaining a high sensitivity because of the NP criterion 
used in training. This would improve the functionality of the system as a complementary 
tool for diagnosis. At 270nm excitation, for cancer vs. normal discrimination, we 
obtained a sensitivity of96% and specificity of93.3% with an AVe of 0.986, excellent 
results for single wavelength excitation compared to that of other studies reported in the 
literature. The NP criterion formally stated in Section 3.3 essentially allows the training 
of an algorithm so as to find a decision rule that maximizes the specificity while holding 
the sensitivity to a high value. This threshold or significance level can be changed by the 
user to produce algorithms tailored to specific aims. For the classification involving the 
spectral dataset, we sought to guarantee a sensitivity of 88% and hence (1=0.88 was used. 
When the dimension reduction method, PLS, was used to reduce the spectral dimension 
before SVM classification, we could still obtain good classification results using far 
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fewer attributes as shown in Table 3.6. PLS reduces the size of the attributes or feature 
size and not the group size so when training seeks to maximize overall accuracy, the 
classifier can still be prone to seeking a rule that favors the group with the larger size at 
the expense of the group with the smaller size. Hence the advantages of training subject 
to the NP criterion still hold true. For the classification involving the PLS-Cs, the desired 
value was 0.=0.8. The main aim of using the PLS selected features was to obtain 
acceptable classification results from a small feature size. 
Traditionally, classification algorithms seek a classifier that maximizes the overall 
accuracy, this SVM algorithm may seek one that selectively maximizes either the 
sensitivity or specificity. This restriction is effective in addressing an unbalanced training 
data set in which one group size far exceeds that of the other group. Most diagnostic 
algorithms based on fluorescence spectroscopy found in the literature haven't accounted 
for data imbalance in binary classification. No study involving ovarian tissue 
fluorescence spectroscopy whether in vivo or ex vivo has addressed this. Thus the study 
here is the first such study to train a classifier for the diagnosis of ovarian tissues with the 
aim of achieving a balance in sensitivity and specificity values regardless of the data 
imbalance between disease and control groups. Moreover, to the best of our knowledge, 
this study is the first to train an SVM on any optical spectroscopy data to tackle the 
skewed classification results that can occur when training data is not balanced. Another 
important aspect that differentiates the SVM algorithm employed here is that the user 
specified parameters are bounded and so the beginning and end points don't have to be 
chosen subjectively. This renders the algorithm far less arbitrary. In a study by Zhu et al. 
in which SVM was used to differentiate between 27 malignant and 94 nonmalignant 
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breast tissue samples, they obtained a sensitivity of 28.1 % and a specificity of 98.1 %, and 
concluded that the skewed classification result is likely due to the data imbalance.45 The 
nonmalignant group was just over 3 times larger than the malignant group in their study 
and they obtained skewed results, in our study the normal group is more than 7 times 
larger than the cancer group and the imbalance is even greater for the classification 
between the cancer and noncancer groups. Yet our classification results are fairly 
unbiased. In general, for binary classification, one is going to find that the diseased 
group is going to be larger than the control group and when a classification rule seeks to 
maximize overall accuracy or minimize the rate of misclassification, the classifier may 
produce skewed results. The NP criterion, as applied here, gives us control over this by 
modulating the threshold. 
The major disadvantage of empirical methods that directly use features from the 
acquired spectrum for diagnosis is that it provides limited knowledge of the changes in 
the tissue biochemistry and morphology that is ultimately reflected in the changes in the 
acquired spectra. Physically based methods to extract parameters directly related to the 
structure of tissues and cellular metabolic processes from a model oftissue fluorescence 
based on the radiative transport theory or monte carlo methods can be used to elucidate 
the disease process. Nonetheless, the shear diagnostic ability of empirical methods is 
obvious and this has lead to physicians in hospitals adopting systems based on empirical 
analysis of fluorescence spectroscopy for use as complementary diagnostic tools. 
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3.7 Conclusion 
Fluorescence spectroscopy provides a real time technique to analyze 
morphological and biochemical processes that accompany tissue changes leading to 
cancer. This makes it viable as a diagnostic tool for detecting cancer and pre-cancer in 
many organ sites. The use of selected multiple excitation wavelengths throughout the UV 
and visible regions have shown that the discrimination of cancer and precancer from 
normal tissues can be done with sensitivities and specificities that are higher than the one 
provided by current methodologies. However, the use of unbalanced data in which one 
group size is considerably larger than the other in training classifiers may make these 
algorithms prone to skewed results in favor of the group with the larger size. Training 
classifiers subject to the NP criterion in which we maximize the specificity while setting 
constraints such that we are assured a high sensitivity value is a way that prevents the 
classifier bias. In standard cases, the larger group is the normal or control group, which 
means that classifiers may obtain results that have a high specificity but low sensitivity. 
In NP classification, when we seek a classifier that sets constraints to achieve high 
sensitivity values rather than one that seeks overall maximum accuracy, we can obtain 
high sensitivity results and still get high specificity values. We trained an SVM algorithm 
subject to the NP criterion and we obtained excellent sensitivity and specificity values for 
the discrimination of ovarian cancer fluorescence spectra from normal fluorescence 
spectra for each of three excitation wavelengths 270nm, 300nm and 340nm. Excellent 
sensitivity for identification of cancerous tissues results in a tool that can be used for 
ovarian cancer detection. Moreover, the algorithm may be employed in demarcating 
tumor margins and for the monitoring of treatment including response to photodynamic 
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therapy, when used for in vivo applications. We can also select the user specified 
significance level to guarantee a high specificity value, while maximizing the sensitivity. 
This type of classifier can especially be useful in the selection of optimal biopsy 
specimen and reducing the problematic cases oftaking unnecessary biopsy samples. This 
in tum cuts down the time needed for traditional diagnosis and also the amount of 
sedatives that is used during conventional biopsy. Moreover, 270nm gave us great 
classification performance that was comparable to that of the diagnostically important 
wavelength of 340nm. This underscores the importance of this wavelength and the 
underutilized uve region in developing classifiers with high diagnostic accuracy for the 
detection of cancer. Further studies including even larger sample sizes than the one in this 
study need to be done to access the potential of this wavelength region. In vivo studies 
utilizing low power levels of excitation, to safeguard against tissue mutagenecity, are also 
warranted. Other organ sites, especially ones that are known to develop cancer in its 
superficial layers such as the cervix, may also benefit from diagnostic algorithms in this 
fluorescence wavelength region. The potential for detecting precancerous lesions and 
other tissue abnormalities such as inflammation in these organ sites should also be 
studied. Fluorescence spectroscopy systems offer a tool for the objective and automated 
diagnosis and screening of cancer and the use of well tailored diagnostic algorithms such 
as the NP SVM algorithm used in this study would further improve the capabilities of 
these systems. 
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lChapter 4: 
Needle Compatible Reflectance Fiber Bundle Endoscope 
4.1 Introduction 
We developed a miniature-sized high-resolution low-cost reflectance-mode fiber 
microscope (RFM) aimed at optical tissue biopsy applications that uses polarized 
imaging configurations to suppress background noise from specular reflectance. The 
RFM is equipped with an air-cooled light-emitting diode illumination module and a 
single 450-~m outer-diameter fiber bundle image guide which is compatible with a 20-
gauge needle. The dual illumination and image acquisition nature of the fiber bundle 
simplifies the system and reduces the total cost. Imaging tests with a US Air Force 
resolution target demonstrate a lateral resolution of -3.5 ~m. The performance ofthe 
imaging system was evaluated by examining samples of green onion skin cells, cultured 
breast cancer cells, and excised human oral cancer tissue. Still and video rate images are 
obtainable in reflectance mode using intrinsic contrast. 
Standard histopathology requires surgical removal of suspect tissue for 
examination, limiting its applicability in routine cancer screening and low-invasive 
cancer diagnosis. Less invasive techniques, from core needle biopsy to fine-needle 
aspiration biopsy, must remove a tiny piece of the suspect lesion from its surrounding 
tissue. To better examine the suspect lesion, endoscopic imaging techniques have 
advanced to employ a wide range of modalities including fiber scanning confocal 
1 This has been adapted from reference 20 
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microscopy in both reflectance86-88 and fluorescence89,9o modes. These techniques employ 
an optical fiber or fiber bundle to view the surface of interior-body cavities. The optical 
fibers are illuminated at the proximal fiber end and images are created by scanning 
mechanisms positioned at either the distal or proximal ends of the fiber. These types of 
systems can capture point by point a high-resolution image from a larger field ofview.91-
93 Furthermore, because high energy can be channeled to each image pixel, the sensitivity 
of the system can be very high. 
Recent advances in simple, low-cost optical-fiber based fluorescent imaging 
systems have permitted the fabrication of this type of endoscopic imaging apparatus with 
limited resources. 18,19,94 This imaging technique is based on transferring inner-body 
images outside the body via a coherent multi-mode fiber bundle, and then directly 
capturing the image using an off-the-shelf digital camera. The resolution of modem 
digital cameras is such that the image resolution is limited by the individual fibers of the 
fiber bundle. In addition, imaging using a digital camera offers the advantage of high 
imaging speed and the possibility of capturing single image frames without scanning. A 
fluorescent-mode fiber endoscope has been developed by Muldoon et al. that achieves a 
resolution of -4.4 /lm. 18,94 We are developing a high-resolution (-3.5 /lm) reflectance-
mode endoscope that is flexible, compatible with a 20-gauge needle, and that can 
generate still and video rate images from intrinsic contrast of biological structures. 
Reflectance-mode endoscopic imaging can potentially complement fluorescence imaging 
by capturing information not available in fluorescence mode and by functioning in 
situations when fluorescent imaging is hard to achieve. In this study, we present a needle-
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based high-resolution reflectance-fiber microscope (RFM) developed for optical tissue 
biopsy applications. 
4.2 System Assembly 
The RFM was assembled on a portable 18 x 24 x 112 inch3 aluminum breadboard 
to facilitate eventual clinical trials. As shown in Figure 4.1 , an air-cooled light-emitting 
diode (Luxeon; white LED, model LXHL-NWE8; blue LED, model LXHL-NRR8) 
served as the illumination source to keep the RFM as compact as possible and also 
reduced the system cost. 
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Figure 4.1- Schematic of the reflectance fiber imaging system 
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The light from the LED is collimated by an integrated collimating lens and passes 
through a linear polarizer (Figure 4.1), after which the polarized light is reflected by a 
glass slide positioned at ~45° (with respect to the beam trajectory) and projected onto an 
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infinity-corrected lOx objective lens (Newport, model: L-I0x, 0.25NA). The objective 
lens and a fiber chuck (Newport, model: FPH-DJ) are positioned with a multimode fiber-
coupler positioner (Newport, model: F-915T). By careful alignment, the illumination 
light is focused into the incident end of a 450-l..lm outer-diameter fiber image guide which 
is positioned by the fiber chuck (Sumitomo Electric, model: IGN-037/10, 104 fiber 
elements in a picture area of333 I..lm diameter, 0.35NA).95 Finally, the imaging end ofthe 
fiber image guide is inserted into the core of a 20-gauge needle and positioned in contact 
with the samples. Light scattered from the samples is collected by the same illumination 
fiber and passes back through the same lOx objective lens and glass slide just described 
previously (see Figure 4.1). 
A CCD color camera (Edmund Optics, model: EO-0813C) coupled with a circular 
polarizer filter (Nikon, 62mm) is used to sample the fiber bundle elements for image 
acquisition. Because the polarization orientation of the S-polarized illumination light is 
perpendicular to the plane of incidence with respect to the glass slide (Le., the plane of 
the Figure 4.1), a significant portion is reflected toward the incident end of the fiber 
bundle to be delivered to the imaging end of the fiber bundle. Specular reflectance from 
the incident end of fiber bundle is also partly reflected away by the glass slide, and the 
remaining specular reflectance is further suppressed by the circular polarizer in front of 
the CCD camera that passes P-polarized light with respect to the plane of incidence. 
Theoretically, only rays that result from multiple scattering events and change their 
polarization to the parallel direction can be detected by the CCD camera (e.g., light 
scattered from the sample). Thus, noise from specular reflection from the incident end of 
the fiber bundle is greatly suppressed, and clearer images are collected. 
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4.3 Imaging Demonstration 
Figure 4.2(a) shows the reflectance image of the fiber-bundle imaging end when 
the needle microscope is positioned in air. Light from the white LED that is reflected 
from the glass-air interface at the imaging end of the fiber bundle is successfully detected 
by the CCD camera, and individual fibers of the fiber bundle are resolved (Figure 4.2(a)). 
(a) (b) 
(c) (d) 
Figure 4.2- Reflectance images of the fiber-bundle tip glass/air interface showing greatly 
reduced background noise from specular reflectance with this RPM system in comparison 
with the non-polarized imaging system. The images (a) and (b) were obtained with cross-
polarized illumination and imaging filters. For image (a), the fiber tip was in air. For 
image (b) fiber tip was covered with a drop of water. Images (c) and (d) were obtained 
without polarized illumination and imaging filters. Image (c) is with the fiber tip in air, 
whereas image (d) is with the fiber tip covered with a drop of water. 
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With the imaging needle of the RFM immersed into a vial of water or phosphate-buffered 
saline (PBS) solution, the RFM field of view is almost completely dark because of the 
close match between the refractive indices of water and the glass fiber results in 
dramatically reduced internal reflection from the imaging end of the fiber bundle. 
Figure 4.2(b) is obtained with a drop of water covering the tip of the imaging fiber 
bundle, which mimics the immersion of fiber tip in water, to provide clear image features. 
It is clear that much less internal reflection occurs from the imaging area covered by 
water [Figure 4.2(b)] compared with the same area when it is exposed to air. Figures 
4.2(a) and (b) were captured with the same imaging configurations and the index-
matching effect is clear. When used in biological or clinical environments, the fiber-
bundle tip is always covered by liquids such as body fluids, etc. Therefore, dipping the 
fiber-bundle tip into water closely mimics the conditions of a real imaging application. 
Moreover, in liquid solution, the reduced internal reflectance leads to a dark field of view 
and a decrease in background noise for biological imaging. Thus, light scattered by 
biological scatterers can be clearly distinguished and cellular images can be obtained. In 
comparison with the polarized reflectance-mode images in Figures 4.2(a) and (b), images 
shown in Figures 4.2(c) and (d) were captured with a reduced exposure time under the 
same imaging conditions but without the illumination and collection polarizers. The 
specular-reflectance noise from the optical components makes it impossible to obtain 
useful information from Figures 4.2(c) and (d). 
The imaging ability of the RFM was tested with a US Air Force resolution target 
and green onion skin cells. The white LED was used to acquire the images and plots 
shown in Figures 4.3(a) to (c). Figure 4.3(a) shows an imaging resolution of -3.5 ~m 
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(-,143 line pairs/mm) obtained upon imaging the US Air Force resolution target. Figure 
4.3(b) shows that the contrast's decreasing slightly from low (64Ip/mm) to high 
(l28Ip/mm) resolution, but it also reveals high frequency components due to the probe 
fibers (3.3 J.lm dia.). Figure 4.3(c) was obtained by using the same white LED-illuminated 
RFM to image the skin tissue of a green onion. The cell walls of the rectangular cells of 
the green onion skin96 are clearly resolved in the image. Note that water was used in all 
the tests to provide refractive index matching. 
(a) 
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Figure 4.3- Processed endoscopic images of (a) USAF resolution target showing the 
resolution of ~143Ip/mm, acquired with white LED illumination, (b) cross sections of 
two resolution line-pair sets showing both the line-pair intensity variation and variation 
due to probe fibers (3.3J.!m dia.), (c) onion skin cells, where arrows show the resolved cell 
walls, acquired with white LED illumination, and (d) cultured SKBR3 cancer cells, 
where the arrows indicate resolved single cells, acquired with blue LED illumination. 
(Scale bar: 50J..lm) 
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The LED light source is cost effective and is easy to change. An air-cooled blue 
LED was used to image cultured SKBR3 human carcinoma cells. Before imaging, 
SKBR3 carcinoma cells were cultured in a 6-mm plate at 37°C for 2 days. We immersed 
the fiber-bundle tip into the culture medium through a needle and focused onto a group of 
cancer cells attached to the culture plate. As shown in Figure 4.3( d), the cancer cells can 
be visualized with the RFM (using blue-LED illumination). The same RFM was also 
tested using excised human oral cancer tissue obtained from the Cooperative Human 
Tissue Network (CHTN). 
(a) (b) 
Figure 4.4- Endoscopic images of excised oral cancer tissue (a) processed image showing 
cellular structures, and (b) processed image with drawing lines indicating the estimated 
cell boundaries. (Scale bar: 50 ~m) 
The tissue was put in a culture plate with PBS, which was then placed on a two-
dimensional translation stage. The needle and fiber-bundle tip were inserted into the 
tissue sample and cellular structures were visualized, as shown in Figure 4.4. The same 
RFM used to image the reflectance from a dust particle in liquid solution resulted in 
single-pixel fiber resolution. 
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In this study, we report a high-resolution RFM developed for optical-tissue biopsy 
applications. The resolution of this fiber microscope is limited by the fiber size of the 
imaging fiber bundle. For the specific fiber-bundle image guide presented in this study, 
the resolution is -3.5 .... m. The reported RFM system uses the same fiber-bundle guide for 
both illumination and imaging. A pair of cross-polarized filters is used in addition to the 
fiber-bundle guide to achieve high-resolution reflectance-mode microscopic imaging. 
The fiber-bundle guide is 450 .... m in diameter, which makes it compatible with current 
clinical needle tissue biopsy systems. This RFM system can work without external agents 
when there is enough endogenous imaging contrast, and it can also be used with 
functionalized contrast agents to enhance image quality and to acquire targeted images 
for diagnosis. Moreover, with easy filter changes, the current RFM system can be easily 
converted to a fluorescence-mode needle-biopsy imaging system similar to the one 
developed by Muldoon et al .. 94 
4.4 Conclusion 
A low-cost endoscopic RFM system has been developed using polarized imaging 
strategies to achieve real-time images of biological samples. A proof-of-concept study, 
demonstrating cellular level images obtained with the compact fiber microscope has been 
presented. Images including that of human tissue and plants have been used to 
demonstrate the system's capability. Future work including the use of LEDs of varying 
illumination wavelengths and power are being investigated to further evaluate and 
enhance the imaging potential of the needle-compatible RFM endoscope. 
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lChapter 5: FTIR Absorption Spectroscopy for the Detection of 
Cervical Cancer: Spectroscopy of Formalin Fixed Tissues 
5. 1 Introduction 
FTIR spectroscopy depends on the absorption and vibration of molecules in the 
infrared region (400-4000cm-1) ofthe electromagnetic spectrum. Analysis ofFTIR 
spectra represents a powerful tool that can access the physiological and biological 
modifications of tissues that are related to changes in molecular structure and molecular 
interactions. The IR spectra of various organ sites show many similarities in their main 
spectral features since biological tissues share the same basic constituents which are 
proteins, carbohydrates, lipids and nucleic acids.98 IR spectroscopy presents a promising 
potential to detect tissue abnormalities which arise with the onset of disease.99 A number 
of groups have reported on the ability of FTIR spectroscopy and microscopy to convey 
useful information that may be employed by pathologists in the classification of tissue 
samples. It has been shown that Infrared (IR) spectroscopy may be used to distinguish 
normal and cancerous colorectal cells, normal and neoplastic lung tissues, normal and 
leukemic lymphocytes; normal, dysplastic and malignant ovarian tissues and normal and 
carcinoma breast tissues. 100-104 Previous studies have reported on the analysis of the FTIR 
spectra of various types of cervical tissues including dysplastic squamous epithelium, 105 
cervical adenocarcinoma,98 malignant radiotherapyl06 and normal tissues. 107 
Cervical cancer is a prevalent gynecological cancer among women both in the 
developed and the developing world. In the United States, the incidence and mortality of 
the disease has declined considerably over the past several decades due to frequent use of 
1 This work is adapted from Reference 97 
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the Pap smear to detect pre-invasive cases of cervical cancer. Yet, a considerable number 
of cases are still diagnosed during the late stages of the disease when the tissues are 
clearly malignant. Moreover, in the developing world, which account for about 80% of 
new cases of cervical cancer, many women have never had a Pap smear. lOS These reasons 
underscore the need for research into finding new diagnostic protocols for cervical cancer. 
Our aim in this study is to provide an exhaustive analysis of the differences 
between the spectra of normal and cancerous cervical tissues and to develop algorithms 
that may be useful in the diagnosis of cervical cancer. Our methods of analysis include 
ratio analysis of pertinent bands in the fingerprint region, t-test measure of significant 
differences and multivariate classification algorithms which involve the methods of 
Partial-Least Squares (PLS), Linear Discriminant Analysis (LDA) and Support Vector 
Machines (SVM). Partial-Least Squares (PLS) is a powerful regression method that 
decomposes an original set of descriptors representing a sample into a smaller set of 
variables. The method can also be seen as a transformation ofthe original data space into 
a new coordinate system with fewer dimensions. LDA methods attempt to find a linear 
transformation (discriminant function) between two variables which maximize the 
variance between groups and minimizes that within groups. SVM, as explained in 
Chapter 3, is a supervised learning method that maps a given dataset into a higher 
dimensional space where a maximal separating hyperplane is constructed to separate 
input data into groups. These statistical analysis methods have been applied in the 
analysis of spectroscopic data in prior studies.45,109-113 We implement hybrid algorithms, 
involving combinations of the above methods and use them to classify FTIR spectra of 
cervical tissues. A leave-one out cross-validation procedure was used to validate our 
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algorithms. A lot ofthe past studies oftissue FTIR spectra used formalin-fixed paraffin 
embedded (FFPE) tissues. But it has been shown that formalin-fixed tissues are more 
suitable for IR spectra analysis, as they could better provide information pertaining to 
tissue biochemistry.ID6 Hence, we use formalin-fixed tissues rather than FFPE tissues in 
this study. 
5.2 Experiments 
5.2.1 Materials and Methods 
Formalin fixed-frozen cervical tissue samples were obtained and stored at -80DC. 
Our tissue samples included that from cancerous sites of 18 patients who had been 
diagnosed with cervical cancer and sites from17 healthy (normal) volunteers. Our 
methods involved cutting 10J.llll microtome sections from the tissue samples. The 
microtome sections were placed on ZnSe windows and mounted in a sample holder for 
transmission analysis. Prior to each spectra collection, the sample chamber was purged 
with dry nitrogen so as to remove the interference of water vapor and C02 from the 
spectra. The background spectrum was collected on a ZnSe window without any tissue 
sample and a typical representation is shown in Figure 5.1. The peaks around 1600cm-1 
and 3500cm-1 are attributed to water vapor absorption and the strong central peak at 
around 2300cm-1 is due to atmospheric C02. The spectra was obtained with a Thermo-
Nicolet Nexus 670 FTIR spectrometer using signal averaging of 512 scans at a resolution 
of about 2 cm- l in the range of 700 - 4000 cm- l . Our spectra pre-processing included 
expansion, optional smoothing, water vapor correction and avoidable baseline correction. 
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Prior to any statistical analysis, all acquired spectra were normalized to peak intensity in 
the amide I region. This serves to eliminate any changes in intensity that may result from 
fluctuations in our section thickness. In our analysis, we utilized the fingerprint region of 
900 -1750 cm- I . An example spectrum for both the cancer and normal groups is shown in 
Figure 5.2. 
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Figure 5.1- Typical single beam background spectrum collected from a ZnSe window. 
Peaks corresponding to atmospheric CO2 and water absorption are observed and hence 
sample chamber is purged prior to collecting spectra from tissue. 
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Figure 5.2- Example FTIR spectra for cancer and normal cervical tissue samples. Spectra 
are normalized to the peak intensity in the amide II band. 
5.2.2 Statistical Analysis 
After collecting the spectra, intensity ratios of the peaks of prominent bands were 
calculated, and their mean was compared for the cancer and normal groups. In calculating 
a ratio, the peak intensity value in the amide II band at around 1548 cm- I was used as the 
denominator, and the peak value for any of the other bands was the numerator. Figure 
5.3 shows the comparison of the mean intensity ratios between the groups. A 2-tailed t-
test was used to test for statistically significant differences of the calculated ratios 
between the two groups. A p-value less than 0.05 was accepted as statistically significant. 
Multivariate algorithms involving PLS, SVM, and LDA were constructed for the 
classification of the tissue spectra. The PLS algorithm has as its input the intensity values 
over the entire wavelength region (900 -1750 cm- I ) of the FTIR absorption spectrum. It 
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Figure 5.3- Mean intensity ratios of the different bands throughout the fingerprint region 
in the mid-IR are compared for the cancer and normal groups. A 2-tail t-test proved that 
the 108011548 and the 1400/1548 ratios showed statistically significant differences 
between the two groups. 
PLS is a dimension reduction technique that in constructing latent components includes 
information in the predictive variables as well as their data labels. So in this case, to 
arrive at the components, not only does PLS just seek variation in the intensity 
measurements, but it also takes into consideration, the corresponding label( or group) of 
each membership, for instance whether the measurement is from a cancerous or normal 
tissue. In this sense, PLS is a supervised learning method while PCA is unsupervised. 
Section 3.4.1 has more information on PLS and PCA methods. The absorption spectra 
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was normalized and mean-centered before being inputted into the PLS procedure. The 
root-mean-squared-error of cross validation (RMSECV) was used to validate the PLS 
procedure to determine the optimal number of components that characterize the model. 
F or our data, the PLS algorithm selected scores from 5 principal components as an 
optimal representation for each measured spectrum. The scores were then transferred to a 
LDA and SVM algorithm to form the PLS-LDA and PLS-SVM classification algorithms 
respectively. A flowchart of the algorithm development process is depicted in Figure 5.4. 
Sensitivity/ 
Specificity 
Figure 5.4- A flowchart of the algorithm development process. 
A leave-one out cross-validation procedure was used to validate our PLS-LDA and PLS-
SVM algorithms. Cross-validation is employed in testing classifiers when there are not 
enough samples to divide the dataset into a training/calibration set and a testing set. The 
premise is that the predictive ability of a model formed on part of a data (training set) can 
be tested out by how well it predicts the remainder of the data.69 The idea of cross-
validation, as mentioned in Chapter 3, involves dividing a dataset into p subsets and using 
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p-1 subsets to build a statistical model and testing this model on the left out subset. A 
total ofp different models are built, each model excluding a unique subset (containing 
samples not included in training the model) to be tested. 
5.3 Results and Discussion 
Our results indicate that FTIR spectral analysis can access differences between the 
spectra of cancer and normal cervical tissues. A careful examination of Figure 5.2, which 
gives an example spectrum for the cancer and normal groups, indicates that, the 
differences in spectra are observed throughput the fingerprint region. The figure shows 
that The IR spectra of tissue in the fingerprint region is dominated by peaks in the amide 
I (around 1650 cm"I) and amide II (around 1548 cm"I) bands of proteins. The amide I 
peak results from a stretching motion of the C=O group whilst the amide II peak is 
mainly attributed to a coupled C-N stretching and a CNH deformation. The differences 
in the amide I and II bands between the cancer and normal groups were minimal. Table 
5.1 summarizes contributions from some of the important tissue constituents that 
contribute to absorption in the mid-IR. A plot of the mean intensity ratios in Figure 5.3 
shows the differences at peak intensity values of various bands in the spectra. The mean 
intensity values were calculated from the mean spectra of the cancer sites (comprising 47 
measurements from the 18 cancerous samples) and the mean spectra of the normal sites 
(comprising 43 measurements from the 17 normal samples). We measured spectra from 
2-4 sites of each tissue sample. A main contribution to the 1400 cm"I band is from 
asymmetric and symmetric vibrational modes of methyl groups ofprotein.98 
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Absorption Corresponding biomolecules and their functional groups 
band (cm-l) 
1650 Amide I band arises from in plane c=o stretching vibration weakly 
coupled with C-N stretching and in plane N-H bending of the amide 
group in proteins 
1540 Amide II band which arises from the N-H bending vibration strongly 
coupled to the C-N stretching vibration of protein 
1400 and 1456 Symmetric and asymmetric CH3 bending modes respectively of the 
methyl groups of proteins 
1080 Symmetric phosphate PO-2 stretching modes (VSPO-2) of nucleic acid 
and the vibrational modes of collagen carbohydrate residues 
1240 Asymmetric phosphate (PO-2) stretching modes (vas PO-2 ) of nucleic 
acids and the amide III/CH2 wagging vibrations of collagen 
1162 C-O stretching mode of the C-OH group of tyrosine residues and C-O 
groups of carbohydrates 
1025 Vibrational modes of -CH2 OH groups and C-O stretching coupled 
with C-O bending of the C-OH groups of carbohydrates respectively 
970 O-P-O antisymmetric stretching mode of DNA or to a phosphate 
monoester band of phosphorylated proteins and nucleic acids 
Table 5.1- ThIS shows some ofthe the vast number ofbiomolecules that contribute to 
FTIR absorption spectra of tissue in the mid-IR fingerprint region. 
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There was an increase in the peak intensity of this absorption band for the cancer group 
over the normal group. Less prominent protein peaks are also observed at the amide III 
peak (around 1240 cm"l) which is mainly due to asymmetric phosphate PO"2 stretching 
. /CH "b t' . 11 \14,115 Th modes of nucleic acids and the amide III 2 waggmg VI ra Ions m co agen. e 
difference in the 1240/1548 intensity ratio wasn't statistically significant (P > 0.05). The 
difference in the 108011548 ratio was statistically significant between the two groups. 
The normal tissues had a greater absorption than the cancer tissues in the 1080 cm"1 band. 
This band primarily originates from symmetric phosphate PO" 2 stretching modes (vsPO" 2) 
of photodiester groups in nucleic acids and the vibrational modes of collagen 
residues.98,114 The band at 970 cm"1 arises from phosphate monoester bands of nucleic 
acids and phosphorylated proteins. The changes between the cancer and normal groups 
are distributed throughout most of the fingerprint region of the absorption spectra, and 
univariate methods, such as intensity ratio analysis don't make full use of the entire 
absorption spectra. Hence, multivariate analysis involving PLS was applied to evaluate 
the data. Figure 5.5 depicts a cluster plot for the cancer and normal groups using PLS 
scores from two of the selected PLS components (PC5 vs. PC3). The PLS procedure 
couldn't fully differentiate all of the samples used in this study, as shown by an overlap 
between some ofthe points from the cluster ofthe normal group and some points from 
the cluster of the cancer group. Nonetheless, the algorithms developed, gave high 
sensitivity and specificity values as shown in Table 5.2. Both algorithms gave a 
sensitivity of91% (43/47) and a specificity of88% (38/43). This good classification 
results, which match that of other spectroscopy techniques, may suggest that the different 
spectral bands in the mid-IR region are diagnostically significant and that the exploration 
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of imaging systems using a few excitation wavelengths that belong to any of these bands 
for further tissue studies may yield important findings . 
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Figure 5.5- A plot depicting clusters ofPLS scores for the normal and cancer groups. 
The data points in the plot are scores from two PLS components, PC3 and PC5. 
PLS-LDA PLS-SVM 
Sensitivity 91% 91% 
Specificity 88% 88% 
Table 5.2- Results of the algorithms in classifying between the normal and cancer tissue 
groups. The SVM classification produced the same results as the LDA classification. 
76 
5.4 CONCLUSION 
In conclusion, we have examined the FTIR spectra of formalin-fixed frozen tissue 
sections of the cervix. We presented intensity ratio analysis of some of the pertinent 
absorption peaks and showed that there is significant variation between the spectra of 
normal and cancerous tissues throughout the fingerprint region. We further examined the 
differences between the spectra of the two groups by using the multivariate statistical 
analysis method ofPLS. Two multivariate classification algorithms were then developed 
using scores from the PLS components. The algorithms were used to classify spectra into 
normal or cancer histopathological groups with high specificity and sensitivity values. 
The analysis methods we have used have made it possible to present a thorough study of 
the differences between the spectra of normal and cancerous tissues of the cervix. FTIR 
spectra analysis is very promising as an easy and fast method that may aid physicians in 
the diagnosis of cervical cancer. 
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Chapter 6: QCL based Mid-IR Imaging System 
6.1 Introduction 
Many tissue biochemical constituents have vibrational wavelengths in the 
fingerprint region (900 -1750 cm-1 (5.7-11J.1ll1)) of the mid- infrared(mid-IR) portion of 
the electromagnetic spectrum.116,117 In Chapter 5 we presented FTIR spectroscopy work, 
that showed that absorption of the functional groups in some of the biomolecules vary 
significantly between the spectra of cancer and normal tissues of the cervix. As we noted 
in the chapter, many studies have found significant differences in the FTIR spectra, 
particularly in the fingerprint region, of normal and cancer tissues in other organs as well. 
In this chapter we present work on the development of a mid-IR imaging system that uses 
a quantum cascade laser (QCL) as an illumination source. The wavelength of the source, 
9.53~m, was informed by the FTIR spectroscopy work which identified it as a possible 
diagnostically relevant wavelength that can distinguish between cancer and normal 
tissues. Some work has been done on the use of FTIR spectroscopic imaging technique 
for tissue studies. \05,118-123 This technique simply uses a focal plane array (FPA) in place 
of a single point detector and generated pseudo-color images that map pixel values to the 
detected intensity values to increase the contrast between the diseased and normal regions 
of tissue. The technique uses broadband light sources which are limited in power, spectral 
density and brightness which in turn limits the possible applicability of this in in vivo 
tissue studies. The use of laser sources that can deliver high spectral density and high 
brightness would be advantageous. Very few studies have been conducted on laser based 
mid-IR microscopy/imaging and even fewer have been concerned with investigation into 
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clinical diagnosis. Mid-IR optical coherence imaging has been developed for bio-
engineered tissues, 124 mid-IR reflectance imaging has been demonstrated on chicken 
tissue and a transmission setup has been used to study celery tissue. 125,126 In this work, we 
have assembled a reflectance based imaging system that uses a continuous-wave QCL 
(cw-QCL) operating in the fingerprint region as a light source. When the reflectance 
imaging system is optimized in the future, it should be capable of the imaging of human 
tissues. 
6.2 Background 
The mid-IR region hasn't been widely explored for imaging due to the lack of 
appropriate light sources and enabling passive components.127 The resolution for infrared 
(IR) microscopy is generally worse than that for visible light microscopy. Some of the 
contributing factors for this are the relatively low numerical apertures (NA) of the 
objectives, the higher wavelengths and the low brightness of conventional IR sources. 
QCLs are semiconductor laser sources of very high brightness which allow for sensitive 
detection of analytes. 125 The high brightness of QCLs, compared to more conventional 
sources, make them very suitable imaging sources. This advantage is very important for 
our intended application of tissue imaging in which we aim to explore biochemical and 
morphological contrast between normal and cancer tissues. Figure 6.1 depicts a graph 
showing FTIR absorption of cancerous breast tissues in the 900-1700 cm-1 (6-11Ilm) 
range. The figure illustrates that a wealth of spectral information can be accessed in the 
mid-IR region. 
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Figure 6.1- Representative FTIR spectrum for a breast tissue sample depicting functional 
groups of important tissue biomolecules. 
The IR spectra oftissue is dominated by peaks in the amide I (around 1650 cm-I) 
and amide II (around 1540 cm-I ) bands ofproteins. lol ,128,129 The amide I peak results 
from a stretching motion of the C=O group whilst the amide II peak is mainly attributed 
to a coupled C-N stretching and a CNH deformation. Weaker protein peaks are also 
observed at the amide III peak (around 1240 cm-I) which is due to a coupled C-H / N-
H deformation and a number of side-chain vibrations occur at around 1390 cm -I and 
1450 cm-I.129-J3J All these bands are obvious in the collected spectrum in Figure 6.1. Also, 
it is very important to note that the presence of DNA contributes bands at around 1080 
cm-I , and around 1049 cm-I which is attributed to the P02- stretching vibrations of the 
phosphodiester backbone of nucleic acids. DNA also contributes to the peak at around 
1240 cm.-I 132,133 These DNA bands are important in the differentiation of carcinoma and 
normal tissues. The laser that we used has a wavelength of approximately 9.53J.UU (1049 
cm-I ), which falls in a diagnostically significant absorption band of DNA. 
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6.3 System Setup 
6.3.1 QCL Source 
The QCL was thermoelectrically (TE) cooled since the system is designed to 
eventually be used system in a clinical setting. The QCL was mounted on a cold plate 
which is a TE cooler module (TE Technology Inc., CP-ll 0) with capacity of 11 OW and 
we attached lug-mounted thermistor (TE Technology Inc., MP-2996) with resistance of 
15Kn to monitor the temperature of the plate. A graphene thermal pad was sandwiched 
between the laser and the plate to allow for efficient thermal contact and reliable heat 
conduction. Another thermistor (TE Technology Inc., MP-2379) was used to detect any 
excessive heating and trigger an alarm if overheating were to occur. The TE cooler has a 
fin and fun attached to its hot plate for heat dissipation and was powered by a 24V DC 
supply and controlled by a TE controller (TE Technology Inc., TC-48-20). This TE 
controller was set to operate in a cool-only-mode for the purposes of cooling down the 
cold plate and it regulates the cooler using pulse-width modulation. We applied thermal 
paste to the thermistors before attachment to the cold plate so as to allow for good 
thermal contact. We took further precautions to ensure that the temperature of the cold 
plate was close to the temperature of the sensor as much as possible since the TE 
controller measures the sensor temperature rather than the QCL attached cold plate which 
would be more ideal. These precautions included attaching the thermistor wires to the 
side of the cold plate with an aluminum tape to stimulate heat conduction around the wire. 
This is expected to minimize any temperature lag between the wire and the monitored 
temperature of the sensor heady4 We wanted to be precise in monitoring the QCL 
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temperature so as to prevent any effects of temperature wavelength modulation of the 
device which in turn adds to a robust imaging system. 
We generally operated the QCL between 1 m Wand 10m W of output power. A 
look at the L-I-V curve in Figure 6.2 makes it clear that even at the maximum output 
power of the laser (50mW), the heat load of the QCL per the equation P = I x V is P = 1.1 
x 8= 8.8W is going to fall far short of the maximum capacity of the TE cooler. We 
operated the QCL at a room temperature and the measured ambient was never more than 
3°C above this temperature. 
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Figure 6.2- L-I-V characterization of the QCL laser source. 
nO 
50 
40 
§' 
30 .s II.. 
~ 
0 
a. 
20 
~ o 
0 
1200 
82 
Wavelength (J.!lll) 
9 .60 9 .58 9 .56 9 .54 
150000.-~--~--~--~~--~--~--~--~--__ ~ 
:e 
~ 120000 
~ 
.(i) 
c: 
~ 90000 
Q; 
~ 
a... 60000 
~ 
'0 (J:) 
bf 30000 
--O.7A I 
--O.SA I 
--O.9A 
-- 1.0A 
-- 1.1 A 
-- 1.2 A 
O ;---~---r=-~~-+~~~~~~~~~--~~ 
1 040 1045 
W avenumber (cm-1) 
1050 
Figure 6.3- The emission spectrum of the QCL illumination source. This shows the 
spectral power density as a function of wavelength and operating current. 
The cooling performance graph (not shown here) shows that at the operating temperature 
and the maximum measured ambient the cooling capacity of the TE cooler is around 
110W hence stable and safe operation of the light source is expected. Figure 6.3 shows 
the emission spectrum of the QCL. It gives the spectral power density as a function of 
wavelength and operating current. 
6.3.2 Reflectance Mode Setup 
The system consists of the thermoelectrically cooled cw-QCL as the imaging 
source. Figure 6.4 depicts the simple microscope setup in reflectance mode. In the 
arrangement, the light beam impinges onto a collimator (ZnSe asphere) and made 
incident onto a 50:50 ZnSe beamsplitter. Either a ZnSe lens of focal length 12.7mm or 
BaF2 lens of focal length 25mm is used interchangeably as LI for illumination and 
collection of reflected light from the sample. LI is used to achieve a magnification of 
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about 25x (All lenses have diameter of 25.4mm, have clear aperture ofO.9xdiameter and 
are from ISP Optics). The sample is on a translational stage controlled by LABVIEW. 
The back-reflected light from the sample is collected and focused onto a focal plane array 
(FPA) that is positioned in the image plane. The second lens, L2 of focal length 25mm, 
when used in the setup, magnifies the image ofLl to achieve a desired total magnification 
of around 80x. In selecting aspherics for the lenses, spherical aberration (assuming 
infinite conjugate) is negligible and a resolution of ~6.5Jlm for the objective may be 
achieved. This is at a cellular resolution level, and to obtain useful magnification, 
eliminating blurring effects, we designed the system not to exceed 80x magnification. 
The reflectance mode is investigated because it would be the configuration of choice for 
any potential in-vivo mid-IR imaging application. 
Sample Plane 
Laser 
Figure 6.4- Microscopy setup for reflectance imaging of tissues. BS, Beamsplitter; Ll 
objective lens stage, L2 magnifying lens, Lc collimating lens, M mirror, FPA focal plane 
array detector. 
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The detector is a low cost FPA (Electrophysics Corp., PV-320L). It consists of 
uncooled ferroelectric sensors, with a broadband response range optimized for 8-14Jlm. 
The array resolution is 320 *240 pixels and the Noise-equivalent-power (NEP) is 
estimated to be ~3 x 10-9W and has a pixel pitch of 48.5Jlm. The low spectral sensitivity 
of the camera limits the power of our QCL source to less than 10m W so as to prevent 
saturation. The use of a low cost high NEP detector underscores the fact that the 
microscopic system is cost-effective. Also, the detector didn't have to be cryogenically 
cooled like more sensitive detectors such as Mercury Cadmium Telluride (MCT) and this 
renders the system more viable for clinical applications. 
6.3.3 Example Reflectance Images 
We took images with reflectance mode setup of thin sections of celery tissue. 
About 20Jlm thickness of frozen celery tissue was cut, and placed flat onto a 2mm thick 
ZnSe slide. The slide was placed in a sample holder for imaging. 
Figure 6.5- Imaging of celery tissue at 25x magnification. 
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Figure 6.5 is an image of a 20j.lm thin celery tissue. It should be noted that the image is 
acquired with a barium fluoride biconvex lens (NA of 0.45) which results in substantial 
diffraction loss and loss of resolution rather than the near diffraction limited performance 
that could be obtained from an aspherical ZnSe lens. Moreover, with a relatively small 
NA, the BaF2 lens is substantially slow, hence the depth of field is longer and allows for 
an image to be registered on the camera with less fine-focusing than a faster lens. But the 
slower lens with smaller NA is going to result in considerably worse resolution. This 
accounts for our ability to get an image, but a blurred one using the BaF 2. Nonetheless 
tissue structures are visible as marked in red. 
(a) (b) 
Figure 6.6- (a) Interference pattern projected onto camera (b) USAF resolution target in 
reflectance mode at magnification of 25x. 
QCLs are known to generally have higher divergence than other laser sources, but 
from our observation, this doesn't detract from its usefulness in imaging, since the use of 
a high NA lens can collect most of the light. We observed the Newton's ring interference 
pattern as shown in Figure 6.6(a). In Figure 6.6(b), the imaging of a USAF target in 
reflectance mode is presented. The target is made of patterned chromium bars on a glass 
substrate. The figure obtained at 25x is obtained after the IR beam is reflected off the 
chromium bars and a ZnSe lens with NA 0.9 serving as L 1, just as in Figure 6.4, but 
86 
without L2. is used to image it onto the FP A. The bars are clearly visible and well 
resolved showing the feasibility of microscopic imaging at this wavelength. A camera 
with better NEP and detectivity would further improve the images considerably. 
The gold standard for cancer diagnosis is biopsy, a surgical procedure to remove 
part of the cancer tissue, followed by histology, which involves extensive H&E staining 
and visible light microscopy to confirm the tissue pathology. Another procedure for 
diagnosis involves biopsy followed by immunohistochemistry which includes the 
labeling of tissue constituents such as proteins, lipids and carbohydrates with antibodies 
before microscopic examination. A mid-IR microscope has the advantage compared with 
the above methods, of not needing staining or antibody labeling for contrast but utilizing 
the intrinsic contrast provided by the absorption of proteins, lipids and carbohydrates 
under IR illumination. This clearly gives the mid-IR microscopy additional advantages of 
avoiding the cost of stains or antibodies and bypassing an additional system complexity 
of staining or antibody labeling. In the future, mid-IR coherent microscopy studies could 
add to the current understanding of the molecular basis of cancer as well as offer an 
alternative for the diagnosis of tissues. 
6.4 Discussion and Conclusion 
The FTIR absorption studies showed that the absorption of the functional groups 
of some compounds vary significantly for cancerous and normal tissues. Most of these 
absorptions occurred in the fingerprint region; this suggests that by using a QCL 
illumination source operating in the above region, we should be able to obtain contrasting 
images of biological relevance for diseased and normal tissues. Consequently we 
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designed and assembled a low cost, robust microscopic system which uses a high 
brightness QCL source operating at 9.53Jlm for illumination. In reflectance mode, an 
image of a USAF test target was acquired, and we imaged celery tissue as well. The 
tissue image wasn't very clearly resolved but further optimization and the use of cameras 
with better detectivity should produce better images. Such work could be explored in 
future studies. Our aim here was to describe work on the development of a reflectance 
based IR imaging system that utilize a mid-IR QCL operating in the fingerprint region as 
an illumination source. Such a system has the potential for diagnostic imaging of tissues. 
In vivo studies in organs such as the breast and the skin are especially promising in the 
field of mid-IR imaging. The skin is easily accessible and in vivo spectroscopy studies 
have been able to measure signals with remarkable SNR from it. Intensity variation in the 
hydration level of the skin has been measured as well as bands corresponding to glycerol 
and a host of other compounds. Triglycerol, in particular has been found to be in greater 
quantities in some normal tissues compared to cancerous tissues.135 Additionally, recent 
studies suggest that the compound plays a role in signaling skin cells into reaching 
maturation; this signifies possible potential in helping people with ailments such as non-
melanoma skin cancer and psoriasis which involve the abnormal proliferation and 
maturation in affected skin cells. FTIR spectroscopy using broadband sources has been 
useful in monitoring the concentration of these compounds; a high brightness source such 
as a QCL should be even more sensitive to small changes in the concentration of 
significant molecules. Hence, a novel concept worth implementing is infrared imaging or 
spectroscopy, with a QCL source in the attenuated total reflectance (A TR) mode for the 
diagnosis or treatment monitoring of non melanoma skin cancer. 
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Other organ sites that stand to benefit are the ones that are easily accessible via an 
endoscope such as the colon, esophagus and the gynecological sites of the cervix and the 
uterus. In these organs, a catheter can be passed down the channel of a silver halide probe 
to deliver air to the organ site which would reduce signatures of C02 and H20 in the 
collected data. The use of silver halide probes in conjunction with the free space system 
we have assembled might hold the most promising path to eventual clinical applications. 
The properties that make silver halide probes good candidates for in vivo imaging 
are that they are non toxic in biological tissues, have a broad spectral transmission in the 
mid-IR,136 exhibit low attenuation, and are very flexible and hence can be coupled to an 
endoscope for imaging. The probes have already been very useful in FTIR spectroscopy 
for tissue diagnosis.137-l 40 In an animal study by Katukuri et ai., they measured the FTIR 
spectra of dextran sulfate sodium(DSS) treated mice in the region of 950 - 1800cm-l •l4l 
They found that important differences existed between the spectra of colitis and a control 
group and that the peaks at 1072, 1088 and 1740cm-l had significant diagnostic potential, 
subsequently a PLS algorithm was developed to distinguish colitis and the control group 
with a sensitivity of 93% and a specificity of 88%. DSS is used to induce colitis in mice 
to serve as a representative experimental model for human inflammatory bowel 
disease. l42 In another study, in vivo spectroscopy work was conducted in the colon which 
revealed distinguishing characteristics between normal and cancerous tissues. l43 The 
FTIR spectra was collected with a ZnSe ATR crystal and it revealed that the relative 
intensity at the wavelengths of 1456cm-l and 1413 cm- l was less in normal tissues. 
Another important finding observed similarities between spectra collected noninvasively 
in vivo and that collected in vitro. Ring et al. measured the in vivo spectra of areas of the 
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skin including the forearm and lips with good signal to noise ratio with a silver halide 
probe coupled to a commercial FTIR instrumentY These studies provide evidence of the 
possibilities in in vivo mid-IR applications. Simple improvements and additions to the 
imaging system we have assembled would make it more ready for useful diagnostic 
applications in the future. An MCT FPA detector that is thermoelectrically cooled can be 
used for high sensitivity detection. With the commercial availability of room temperature 
operating QCLs that don't need any cooling, a very portable system for clinical use may 
be realized. Moreover, a widely tunable QCL can be used for illumination to allow for 
some flexibility in wavelength selection as well as the implementation of hyperspectral 
and multispectral imaging modalities to enhance contrast between diseased and normal 
tissues. 
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Chapter 7: Summary and Future Direction 
7.1 Summary 
In this thesis, we explored the application of spectroscopy techniques, new 
algorithms and imaging systems for the diagnosis of gynecological cancers. We 
conducted studies in mid-IR spectroscopy and imaging. We wanted to exploit the vast 
amount of molecules that have vibration frequencies in this region for spectroscopy to 
determine if it is possible to achieve good classifier performance. We measured the 
spectra of cervical tissues and developed classification algorithms for differentiating 
cancer from normal tissues. The performances of the algorithms were comparable to that 
of algorithms developed from UV -ViS optical spectroscopy. A wavelength in one of the 
significant bands in the spectra was selected and used as the excitation wavelength of a 
QCL-based mid-IR microscopic system. With further development in the future, this 
system should be viable for tissue studies and hopefully for accessing diagnostic 
information to aid in cancer diagnosis. 
The UVC region has been mainly neglected in tissue spectroscopy due to the 
possibility of mutagenicity under the interrogation of UV rays. But studies have pointed 
to the fact that low levels of radiation are safe in humans. Given this fact, we trained an 
SVM algorithm on fluorescence spectra excited with UVC light, and we found that the 
classification performance of such an algorithm was comparable to other algorithms 
based on higher wavelengths of excitation. This suggests that this wavelength range has 
promising diagnostic potential. 
91 
We demonstrated the application of an SVM based classification algorithm for 
problems involving unbalanced datasets. These types of datasets can skew an algorithm's 
classification performance when trained in the conventional way for maximizing the 
overall accuracy. We demonstrated the training of an SVM algorithm which was trained 
subject to the Neyman Pearson criterion. In this case we constrained the sensitivity to 
have a high value while maximizing the specificity. Using this approach, fluorescence 
spectra of ovarian tissues were classified into different groups including that of cancer. 
This learning technique leads to fairly balanced classification results, that aren't skewed 
towards the group with the larger size. 
We also assembled and demonstrated the cellular imaging capability of a needle-
based high resolution reflectance fiber microscope. It is an inexpensive system that is 
developed for future biopsy applications using intrinsic tissue contrast. 
Some improvements in our studies are warranted. The use of a large testing 
dataset withheld from training would give us a better idea of the generalization 
performance of the classifiers. Also, the development of classification algorithms to 
classify input data into groups involving precancerous lesions are much needed. For 
instance, in the FTIR classification of cervical data, a very useful outcome would be the 
ability to tell if a given patient has cervical dysplasia. Work also remains to be done on 
the reflectance fiber-mode microscope. We have demonstrated cellular imaging with this 
inexpensively developed system, but ultimately we need to perform in vivo testing of 
organ sites to determine its suitability for use in a clinical setting. Also, the use of 
multiple wavelengths to cover a wider region for mid-IR imaging is needed to elucidate 
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IR images, especially images of tissues. The use of cameras with better detectivity in the 
fingerprint region would also enhance image quality. 
7.2 Future Direction 
In the future, attempting a combination of FTIR and fluorescence spectroscopy to 
attempt to yield better classification results is warranted. Studies have reported the use of 
the combination of fluorescence, diffuse reflectance and light scattering spectroscopy 
methods, referred to as trimodal spectroscopy, to achieve better classification results than 
the use of any one of the techniques. 144 FTIR accesses the vibrational states of 
biomolecules while fluorescence spectroscopy depends on electronic transitions in 
molecules. Ifwe combine these two spectroscopy techniques we get to access more 
properties ofthe different histopathological groups of tissues and may have a better 
chance of finding significant differences that would be diagnostic. Moreover, a combined 
imaging and spectroscopy system which uses the RFM to give visual cellular information 
and either the fluorescence or FTIR technique to provide detailed and broad spectral 
characteristics might yield an improvement in disease diagnosis. 
Given the low prevalence of gynecological cancer diseases, we can still expect 
that the training of classification algorithms for binary classification is going to depend 
on some imbalance in the training data so research methods to address this are warranted. 
Alternative methods of dealing with imbalanced training sets, besides the NP criterion, 
should be studied and used in training spectroscopic data. Other classifiers besides SVM 
can also be studied with respect to the minimax, NP or other learning frameworks to 
determine which one provides the best needed results for cancer diagnosis. Also, novel 
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dimension reduction methods such as sparse PLS or sparse PCA may be explored for the 
analysis of optical spectroscopic data. 
There is tremendous amount of knowledge about tissue biochemistry that can be 
accessed in the mid-IR due to the fact that molecular vibrations occur on the order of 
wavelengths in this region. There is significant tissue absorption in this region, but on the 
other hand there is also low scattering. This can open up applications in coherent imaging 
especially with high brightness sources. With the vast amount of molecules that vibrate in 
the mid-IR, applications such as imaging using intrinsic contrast provided by the tissue 
constituents rather than the use of any expensive dyes are viable clinically. A lot of 
studies have shown the ex vivo diagnosis of tissue using intrinsic contrast and pseudo-
color images. With the recent advances in the development of portable light sources such 
as the QCL and silver halide fibers, one can envision spectroscopy and imaging systems 
that can probe tissue in vivo for relevant diagnostic information. In the future, a tunable 
mid-IR laser with a flexible silver halide probe that exhibit very low attenuation may be 
used to image bulk tissues via the ATR configuration. Subsequently, tissue contrast 
studies of true color and false color images of cancerous and normal tissues may be 
performed to further explore the clinical potential of the mid-IR region. 
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